{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T18:12:57Z","timestamp":1789236777709,"version":"build-2803163510"},"reference-count":478,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-025-11421-1","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T13:45:42Z","timestamp":1766411142000},"page":"4759-4814","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Exploration of the protein and pharmacological landscape of monkeypox virus treatment: from entry point to end point"],"prefix":"10.1007","volume":"30","author":[{"given":"Cena","family":"Aram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Barancheshmeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Alishvandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad H.","family":"Khodabandehloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza H.","family":"Shirvani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhasan","family":"Fotohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Amin","family":"Ghezel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Borji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Keikha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"issue":"1","key":"11421_CR1","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41392-023-01675-2","volume":"8","author":"J Lu","year":"2023","unstructured":"Lu J, Xing H, Wang C, Tang M, Wu C, Ye F et al (2023) Mpox (formerly monkeypox): pathogenesis, prevention and treatment. Signal Transduct Target Ther 8(1):458","journal-title":"Signal Transduct Target Ther"},{"key":"11421_CR2","doi-asserted-by":"publisher","first-page":"102551","DOI":"10.1016\/j.tmaid.2023.102551","volume":"52","author":"N Luna","year":"2023","unstructured":"Luna N, Mu\u00f1oz M, Bonilla-Aldana DK, Pati\u00f1o LH, Kasminskaya Y, Paniz-Mondolfi A et al (2023) Monkeypox virus (MPXV) genomics: a mutational and phylogenomic analyses of B. 1 lineages. Travel Med Infect Dis 52:102551","journal-title":"Travel Med Infect Dis"},{"issue":"11","key":"11421_CR3","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.3390\/v16111737","volume":"16","author":"F Mohamed Abdoul-Latif","year":"2024","unstructured":"Mohamed Abdoul-Latif F, Ainane A, Mohamed H, Merito Ali A, Houmed Aboubaker I, Jutur PP et al (2024) Mpox resurgence: a multifaceted analysis for global preparedness. Viruses 16(11):1737. https:\/\/doi.org\/10.3390\/v16111737","journal-title":"Viruses"},{"key":"11421_CR4","unstructured":"Mpox is still being transmitted across the world, says UN health agency 2024 [Available from: https:\/\/news.un.org\/en\/story\/2024\/08\/1153141"},{"issue":"6","key":"11421_CR5","doi-asserted-by":"publisher","first-page":"106759","DOI":"10.1016\/j.isci.2023.106759","volume":"26","author":"SJR da Silva","year":"2023","unstructured":"da Silva SJR, Kohl A, Pena L, Pardee K (2023) Clinical and laboratory diagnosis of monkeypox (mpox): current status and future directions. iScience 26(6):106759. https:\/\/doi.org\/10.1016\/j.isci.2023.106759","journal-title":"iScience"},{"issue":"8","key":"11421_CR6","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/S1473-3099(22)00228-6","volume":"22","author":"H Adler","year":"2022","unstructured":"Adler H, Gould S, Hine P, Snell LB, Wong W, Houlihan CF et al (2022) Clinical features and management of human monkeypox: a retrospective observational study in the UK. Lancet Infect Dis 22(8):1153\u20131162","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"11421_CR7","doi-asserted-by":"publisher","first-page":"e0007791","DOI":"10.1371\/journal.pntd.0007791","volume":"13","author":"EM Beer","year":"2019","unstructured":"Beer EM, Rao VB (2019) A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy. PLoS Negl Trop Dis 13(10):e0007791","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"11421_CR8","doi-asserted-by":"publisher","first-page":"e0010141","DOI":"10.1371\/journal.pntd.0010141","volume":"16","author":"EM Bunge","year":"2022","unstructured":"Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR et al (2022) The changing epidemiology of human monkeypox-a potential threat? A systematic review. PLoS Negl Trop Dis 16(2):e0010141","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"11421_CR9","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1038\/s41591-022-01907-y","volume":"28","author":"J Isidro","year":"2022","unstructured":"Isidro J, Borges V, Pinto M, Sobral D, Santos JD, Nunes A et al (2022) Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus. Nat Med 28(8):1569\u20131572","journal-title":"Nat Med"},{"key":"11421_CR10","doi-asserted-by":"publisher","first-page":"102577","DOI":"10.1016\/j.tmaid.2023.102577","volume":"53","author":"DO Shomuyiwa","year":"2023","unstructured":"Shomuyiwa DO, Manirambona E (2023) Monkeypox virus declared as a global health emergency: what next for Africa\u2019s preparedness? Travel Med Infect Dis 53:102577","journal-title":"Travel Med Infect Dis"},{"issue":"1","key":"11421_CR11","doi-asserted-by":"publisher","first-page":"2522741","DOI":"10.1155\/ipid\/2522741","volume":"2025","author":"SK Halder","year":"2025","unstructured":"Halder SK, Sultana A, Himel MK, Shil A (2025) Monkeypox: origin, transmission, clinical manifestations, prevention, and therapeutic options. Interdiscip Perspect Infect Dis 2025(1):2522741","journal-title":"Interdiscip Perspect Infect Dis"},{"issue":"10","key":"11421_CR12","doi-asserted-by":"publisher","first-page":"EVIDoa2400189","DOI":"10.1056\/EVIDoa2400189","volume":"3","author":"PA Yu","year":"2024","unstructured":"Yu PA, Elmor R, Muhammad K, Yu YC, Rao AK (2024) Tecovirimat use under expanded access to treat Mpox in the United States, 2022\u20132023. NEJM Evid 3(10):EVIDoa2400189","journal-title":"NEJM Evid"},{"issue":"1","key":"11421_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s41182-025-00708-6","volume":"53","author":"A Ganesan","year":"2025","unstructured":"Ganesan A, Arunagiri T, Mani S, Kumaran VR, Kannaiah KP, Chanduluru HK (2025) From pox to protection: understanding Monkeypox pathophysiology and immune resilience. Trop Med Health 53(1):33","journal-title":"Trop Med Health"},{"issue":"2","key":"11421_CR14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/IM9.0000000000000146","volume":"6","author":"VH Sofiani","year":"2024","unstructured":"Sofiani VH, Rukerd MR, Charostad J, Pardeshenas M, Ghazi R, Arefinia N, Shafieipour S, Salajegheh F, Nakhaie M (2024) From entry to evasion: a comprehensive analysis of host-virus interactions for monkeypox. Infect Microbes Dis 6(2):56\u201364","journal-title":"Infect Microbes Dis"},{"issue":"1","key":"11421_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/zoonoticdis5010003","volume":"5","author":"EM Cambaza","year":"2025","unstructured":"Cambaza EM (2025) A review of the molecular understanding of the Mpox virus (MPXV): genomics, immune evasion, and therapeutic targets. Zoonotic Dis 5(1):3","journal-title":"Zoonotic Dis"},{"issue":"5","key":"11421_CR16","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1080\/17460441.2023.2199980","volume":"18","author":"AA Ezat","year":"2023","unstructured":"Ezat AA, Abduljalil JM, Elghareib AM, Samir A, Elfiky AA (2023) The discovery of novel antivirals for the treatment of mpox: is drug repurposing the answer? Expert Opin Drug Discov 18(5):551\u2013561","journal-title":"Expert Opin Drug Discov"},{"key":"11421_CR17","doi-asserted-by":"crossref","unstructured":"Rohaim MA, Naggar RFE, Atasoy MO, Munir M (2024) Molecular virology of orthopoxviruses with special reference to monkeypox virus. In: Poxviruses, pp 111\u2013124","DOI":"10.1007\/978-3-031-57165-7_7"},{"key":"11421_CR18","doi-asserted-by":"crossref","unstructured":"Petersen BW, Karem KL, Damon IK (2014) Orthopoxviruses: variola, vaccinia, cowpox, and monkeypox. In: Viral infections of humans: epidemiology and control, pp 501\u2013517","DOI":"10.1007\/978-1-4899-7448-8_21"},{"issue":"12","key":"11421_CR19","doi-asserted-by":"publisher","first-page":"e0303501","DOI":"10.1371\/journal.pone.0303501","volume":"19","author":"H Duan","year":"2024","unstructured":"Duan H, Shi Q, Yue X, Zhang Z, Liu L, Wang Y et al (2024) Identification of core therapeutic targets for Monkeypox virus and repurposing potential of drugs: a WEB prediction approach. PLoS ONE 19(12):e0303501","journal-title":"PLoS ONE"},{"issue":"Pt 4","key":"11421_CR20","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1107\/S2053230X17003740","volume":"73","author":"C V\u00e9nien-Bryan","year":"2017","unstructured":"V\u00e9nien-Bryan C, Li Z, Vuillard L, Boutin JA (2017) Cryo-electron microscopy and X-ray crystallography: complementary approaches to structural biology and drug discovery. Acta Crystallogr F Struct Biol Commun 73(Pt 4):174\u2013183","journal-title":"Acta Crystallogr F Struct Biol Commun"},{"issue":"3","key":"11421_CR21","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1586\/14789450.2016.1147353","volume":"13","author":"KK Lum","year":"2016","unstructured":"Lum KK, Cristea IM (2016) Proteomic approaches to uncovering virus-host protein interactions during the progression of viral infection. Expert Rev Proteomics 13(3):325\u2013340","journal-title":"Expert Rev Proteomics"},{"issue":"22","key":"11421_CR22","doi-asserted-by":"publisher","first-page":"5349","DOI":"10.3390\/molecules29225349","volume":"29","author":"M Pappalardo","year":"2024","unstructured":"Pappalardo M, Sipala FM, Nicolosi MC, Guccione S, Ronsisvalle S (2024) Recent applications of in silico approaches for studying receptor mutations associated with human pathologies. Molecules 29(22):5349. https:\/\/doi.org\/10.3390\/molecules29225349","journal-title":"Molecules"},{"key":"11421_CR23","doi-asserted-by":"publisher","first-page":"100100","DOI":"10.1016\/j.soh.2024.100100","volume":"4","author":"A Hossain","year":"2025","unstructured":"Hossain A, Monem MA, Rahman M, Raza R (2025) Mpox (monkeypox): a comprehensive updated of current epidemic evidence. Sci One Health 4:100100","journal-title":"Sci One Health"},{"issue":"4","key":"11421_CR24","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jiph.2023.02.003","volume":"16","author":"A Karagoz","year":"2023","unstructured":"Karagoz A, Tombuloglu H, Alsaeed M, Tombuloglu G, AlRubaish AA, Mahmoud A et al (2023) Monkeypox (mpox) virus: classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis. J Infect Public Health 16(4):531\u2013541","journal-title":"J Infect Public Health"},{"issue":"Pt 10","key":"11421_CR25","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1099\/vir.0.81215-0","volume":"86","author":"AM Likos","year":"2005","unstructured":"Likos AM, Sammons SA, Olson VA, Frace AM, Li Y, Olsen-Rasmussen M et al (2005) A tale of two clades: monkeypox viruses. J Gen Virol 86(Pt 10):2661\u20132672","journal-title":"J Gen Virol"},{"issue":"3","key":"11421_CR26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S1473-3099(23)00055-5","volume":"23","author":"D Ulaeto","year":"2023","unstructured":"Ulaeto D, Agafonov A, Burchfield J, Carter L, Happi C, Jakob R et al (2023) New nomenclature for mpox (monkeypox) and monkeypox virus clades. Lancet Infect Dis 23(3):273\u2013275","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"11421_CR27","doi-asserted-by":"publisher","first-page":"e002019","DOI":"10.1136\/bmjgh-2019-002019","volume":"4","author":"O Oyebanji","year":"2019","unstructured":"Oyebanji O, Ofonagoro U, Akande O, Nsofor I, Ukenedo C, Mohammed TB et al (2019) Lay media reporting of monkeypox in Nigeria. BMJ Glob Health 4(6):e002019","journal-title":"BMJ Glob Health"},{"key":"11421_CR28","doi-asserted-by":"publisher","first-page":"1360586","DOI":"10.3389\/fcimb.2024.1360586","volume":"14","author":"E Alakunle","year":"2024","unstructured":"Alakunle E, Kolawole D, Diaz-C\u00e1nova D, Alele F, Adegboye O, Moens U et al (2024) A comprehensive review of monkeypox virus and mpox characteristics. Front Cell Infect Microbiol 14:1360586","journal-title":"Front Cell Infect Microbiol"},{"issue":"12","key":"11421_CR29","doi-asserted-by":"publisher","first-page":"e0057624","DOI":"10.1128\/msphere.00576-24","volume":"9","author":"B Young","year":"2024","unstructured":"Young B, Seifert SN, Lawson C, Koehler H (2024) Exploring the genomic basis of Mpox virus-host transmission and pathogenesis. mSphere 9(12):e0057624","journal-title":"mSphere"},{"key":"11421_CR30","doi-asserted-by":"publisher","first-page":"105372","DOI":"10.1016\/j.meegid.2022.105372","volume":"105","author":"D Forni","year":"2022","unstructured":"Forni D, Cagliani R, Molteni C, Clerici M, Sironi M (2022) Monkeypox virus: the changing facets of a zoonotic pathogen. Infect Genet Evol 105:105372","journal-title":"Infect Genet Evol"},{"issue":"10","key":"11421_CR31","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1099\/vir.0.045070-0","volume":"93","author":"SWJ Ember","year":"2012","unstructured":"Ember SWJ, Ren H, Ferguson BJ, Smith GL (2012) Vaccinia virus protein C4 inhibits NF-\u03baB activation and promotes virus virulence. J Gen Virol 93(10):2098\u20132108","journal-title":"J Gen Virol"},{"issue":"1","key":"11421_CR32","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.virol.2005.05.030","volume":"340","author":"N Chen","year":"2005","unstructured":"Chen N, Li G, Liszewski MK, Atkinson JP, Jahrling PB, Feng Z et al (2005) Virulence differences between monkeypox virus isolates from West Africa and the Congo basin. Virology 340(1):46\u201363","journal-title":"Virology"},{"key":"11421_CR33","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.virol.2014.11.009","volume":"475","author":"JG Lopera","year":"2015","unstructured":"Lopera JG, Falendysz EA, Rocke TE, Osorio JE (2015) Attenuation of monkeypox virus by deletion of genomic regions. Virology 475:129\u2013138","journal-title":"Virology"},{"issue":"2","key":"11421_CR34","doi-asserted-by":"publisher","first-page":"e0319922","DOI":"10.1128\/spectrum.03199-22","volume":"11","author":"PA Desingu","year":"2023","unstructured":"Desingu PA, Nagarajan K, Sundaresan NR (2023) Unique tandem repeats in the inverted terminal repeat regions of monkeypox viruses. Microbiol Spectr 11(2):e0319922","journal-title":"Microbiol Spectr"},{"issue":"1","key":"11421_CR35","doi-asserted-by":"publisher","first-page":"108601","DOI":"10.1016\/j.isci.2023.108601","volume":"27","author":"PA Desingu","year":"2024","unstructured":"Desingu PA, Rubeni TP, Nagarajan K, Sundaresan NR (2024) Molecular evolution of 2022 multi-country outbreak-causing monkeypox virus clade IIb. iScience 27(1):108601","journal-title":"iScience"},{"issue":"4","key":"11421_CR36","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/s11262-023-02002-1","volume":"59","author":"A Brinkmann","year":"2023","unstructured":"Brinkmann A, Kohl C, Pape K, Bourquain D, Th\u00fcrmer A, Michel J et al (2023) Extensive ITR expansion of the 2022 Mpox virus genome through gene duplication and gene loss. Virus Genes 59(4):532\u2013540","journal-title":"Virus Genes"},{"issue":"2","key":"11421_CR37","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1006\/viro.2000.0799","volume":"281","author":"MN Matrosovich","year":"2001","unstructured":"Matrosovich MN, Krauss S, Webster RG (2001) H9N2 influenza A viruses from poultry in Asia have human virus-like receptor specificity. Virology 281(2):156\u2013162","journal-title":"Virology"},{"issue":"10","key":"11421_CR38","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1099\/vir.0.81215-0","volume":"86","author":"AM Likos","year":"2005","unstructured":"Likos AM, Sammons SA, Olson VA, Frace AM, Li Y, Olsen-Rasmussen M et al (2005) A tale of two clades: monkeypox viruses. J Gen Virol 86(10):2661\u20132672","journal-title":"J Gen Virol"},{"issue":"11","key":"11421_CR39","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nrmicro2222","volume":"7","author":"NC Elde","year":"2009","unstructured":"Elde NC, Malik HS (2009) The evolutionary conundrum of pathogen mimicry. Nat Rev Microbiol 7(11):787\u2013797","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"11421_CR40","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40794-024-00237-w","volume":"11","author":"NG Naga","year":"2025","unstructured":"Naga NG, Nawar EA, Mobarak AA, Faramawy AG, Al-Kordy HMH (2025) Monkeypox: a re-emergent virus with global health implications\u2014a comprehensive review. Trop Dis Travel Med Vaccines 11(1):2","journal-title":"Trop Dis Travel Med Vaccines"},{"issue":"1","key":"11421_CR41","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3390\/v13010043","volume":"13","author":"NIO Silva","year":"2020","unstructured":"Silva NIO, de Oliveira JS, Kroon EG, Trindade GS, Drumond BP (2020) Here, there, and everywhere: the wide host range and geographic distribution of zoonotic orthopoxviruses. Viruses 13(1):43. https:\/\/doi.org\/10.3390\/v13010043","journal-title":"Viruses"},{"key":"11421_CR42","doi-asserted-by":"publisher","first-page":"1277447","DOI":"10.3389\/fimmu.2024.1277447","volume":"15","author":"D Diaz-C\u00e1nova","year":"2024","unstructured":"Diaz-C\u00e1nova D, Moens U, Brinkmann A, Nitsche A, Okeke MI (2024) Whole genome sequencing of recombinant viruses obtained from co-infection and superinfection of Vero cells with modified vaccinia virus ankara vectored influenza vaccine and a naturally occurring cowpox virus. Front Immunol 15:1277447","journal-title":"Front Immunol"},{"issue":"20","key":"11421_CR43","doi-asserted-by":"publisher","first-page":"5540","DOI":"10.1016\/j.cell.2024.08.043","volume":"187","author":"EM Mucker","year":"2024","unstructured":"Mucker EM, Freyn AW, Bixler SL, Cizmeci D, Atyeo C, Earl PL et al (2024) Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates. Cell 187(20):5540\u201353.e10","journal-title":"Cell"},{"key":"11421_CR44","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/bs.aivir.2016.07.001","volume":"97","author":"A Volz","year":"2017","unstructured":"Volz A, Sutter G (2017) Modified vaccinia virus Ankara: history, value in basic research, and current perspectives for vaccine development. Adv Virus Res 97:187\u2013243","journal-title":"Adv Virus Res"},{"key":"11421_CR45","doi-asserted-by":"crossref","unstructured":"Bauer L, Giussani S, Palazzi N, Bot E, Colombo E, Zare F, et al (2025) Dissecting MPXV neurotropism and host antiviral signaling using human stem cell-based models. bioRxiv. 2025:2023.08.25.554849","DOI":"10.1101\/2023.08.25.554849"},{"key":"11421_CR46","doi-asserted-by":"publisher","first-page":"104424","DOI":"10.1016\/j.ebiom.2022.104424","volume":"87","author":"H Li","year":"2023","unstructured":"Li H, Huang Q-Z, Zhang H, Liu Z-X, Chen X-H, Ye L-L et al (2023) The land-scape of immune response to monkeypox virus. EBioMedicine 87:104424","journal-title":"EBioMedicine"},{"issue":"4","key":"11421_CR47","doi-asserted-by":"publisher","first-page":"e35086","DOI":"10.1371\/journal.pone.0035086","volume":"7","author":"PN Hudson","year":"2012","unstructured":"Hudson PN, Self J, Weiss S, Braden Z, Xiao Y, Girgis NM et al (2012) Elucidating the role of the complement control protein in monkeypox pathogenicity. PLoS ONE 7(4):e35086","journal-title":"PLoS ONE"},{"issue":"18","key":"11421_CR48","doi-asserted-by":"publisher","first-page":"9527","DOI":"10.1128\/JVI.00199-11","volume":"85","author":"RD Estep","year":"2011","unstructured":"Estep RD, Messaoudi I, O\u2019Connor MA, Li H, Sprague J, Barron A et al (2011) Deletion of the monkeypox virus inhibitor of complement enzymes locus impacts the adaptive immune response to monkeypox virus in a nonhuman primate model of infection. J Virol 85(18):9527\u20139542","journal-title":"J Virol"},{"issue":"8","key":"11421_CR49","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1016\/j.chom.2021.05.009","volume":"29","author":"H Koehler","year":"2021","unstructured":"Koehler H, Cotsmire S, Zhang T, Balachandran S, Upton JW, Langland J et al (2021) Vaccinia virus E3 prevents sensing of Z-RNA to block ZBP1-dependent necroptosis. Cell Host Microbe 29(8):1266\u201376.e5","journal-title":"Cell Host Microbe"},{"key":"11421_CR50","doi-asserted-by":"publisher","first-page":"1106247","DOI":"10.3389\/fmicb.2023.1106247","volume":"14","author":"M Zandi","year":"2023","unstructured":"Zandi M, Shafaati M, Hosseini F (2023) Mechanisms of immune evasion of monkeypox virus. Front Microbiol 14:1106247","journal-title":"Front Microbiol"},{"issue":"20","key":"11421_CR51","doi-asserted-by":"publisher","first-page":"10489","DOI":"10.1128\/JVI.00304-15","volume":"89","author":"WD Arndt","year":"2015","unstructured":"Arndt WD, Cotsmire S, Trainor K, Harrington H, Hauns K, Kibler KV et al (2015) Evasion of the innate immune type I interferon system by Monkeypox virus. J Virol 89(20):10489\u201310499","journal-title":"J Virol"},{"issue":"7743","key":"11421_CR52","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41586-019-0928-6","volume":"566","author":"JB Eaglesham","year":"2019","unstructured":"Eaglesham JB, Pan Y, Kupper TS, Kranzusch PJ (2019) Viral and metazoan poxins are cGAMP-specific nucleases that restrict cGAS\u2013STING signalling. Nature 566(7743):259\u2013263","journal-title":"Nature"},{"issue":"1","key":"11421_CR53","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.virol.2009.11.008","volume":"397","author":"KE Rehm","year":"2010","unstructured":"Rehm KE, Connor RF, Jones GJ, Yimbu K, Roper RL (2010) Vaccinia virus A35R inhibits MHC class II antigen presentation. Virology 397(1):176\u2013186","journal-title":"Virology"},{"issue":"5","key":"11421_CR54","doi-asserted-by":"publisher","first-page":"100185","DOI":"10.1016\/j.cellin.2024.100185","volume":"3","author":"XM Yi","year":"2024","unstructured":"Yi XM, Lei YL, Li M, Zhong L, Li S (2024) The monkeypox virus-host interplays. Cell Insight 3(5):100185","journal-title":"Cell Insight"},{"issue":"4","key":"11421_CR55","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1128\/MMBR.00027-06","volume":"70","author":"MA Garc\u00eda","year":"2006","unstructured":"Garc\u00eda MA, Gil J, Ventoso I, Guerra S, Domingo E, Rivas C et al (2006) Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol Mol Biol Rev 70(4):1032\u20131060","journal-title":"Microbiol Mol Biol Rev"},{"issue":"1","key":"11421_CR56","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.virusres.2005.10.014","volume":"119","author":"JO Langland","year":"2006","unstructured":"Langland JO, Cameron JM, Heck MC, Jancovich JK, Jacobs BL (2006) Inhibition of PKR by RNA and DNA viruses. Virus Res 119(1):100\u2013110","journal-title":"Virus Res"},{"issue":"6670","key":"11421_CR57","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1126\/science.adg8116","volume":"382","author":"\u00c1 O'Toole","year":"2023","unstructured":"O\u2019Toole \u00c1, Neher RA, Ndodo N, Borges V, Gannon B, Gomes JP et al (2023) APOBEC3 deaminase editing in mpox virus as evidence for sustained human transmission since at least 2016. Science 382(6670):595\u2013600","journal-title":"Science"},{"issue":"1","key":"11421_CR58","doi-asserted-by":"publisher","first-page":"e28036","DOI":"10.1002\/jmv.28036","volume":"95","author":"L Wang","year":"2023","unstructured":"Wang L, Shang J, Weng S, Aliyari SR, Ji C, Cheng G et al (2023) Genomic annotation and molecular evolution of monkeypox virus outbreak in 2022. J Med Virol 95(1):e28036","journal-title":"J Med Virol"},{"issue":"1","key":"11421_CR59","doi-asserted-by":"publisher","first-page":"qzad003","DOI":"10.1093\/gpbjnl\/qzad003","volume":"22","author":"KJ Shan","year":"2024","unstructured":"Shan KJ, Wu C, Tang X, Lu R, Hu Y, Tan W, Lu J (2024) Molecular evolution of protein sequences and codon usage in Monkeypox viruses. Genom Proteom Bioinform 22(1):qzad003. https:\/\/doi.org\/10.1093\/gpbjnl\/qzad003","journal-title":"Genom Proteom Bioinform"},{"issue":"2","key":"11421_CR60","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1620\/tjem.2023.J057","volume":"261","author":"T Akaishi","year":"2023","unstructured":"Akaishi T (2023) Recently added frameshift mutation in human monkeypox virus (hMPXV) OPG191 gene. Tohoku J Exp Med 261(2):103\u2013107","journal-title":"Tohoku J Exp Med"},{"issue":"4","key":"11421_CR61","doi-asserted-by":"publisher","first-page":"111","DOI":"10.32607\/actanaturae.11857","volume":"14","author":"SN Shchelkunov","year":"2022","unstructured":"Shchelkunov SN, Sergeev AA, Titova KA, Pyankov SA, Starostina EV, Borgoyakova MB et al (2022) Comparison of the effectiveness of transepidermal and intradermal immunization of mice with the vacinia virus. Acta Nat 14(4):111\u2013118","journal-title":"Acta Nat"},{"issue":"1","key":"11421_CR62","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12863-023-01171-0","volume":"24","author":"J Zhu","year":"2023","unstructured":"Zhu J, Yu J, Qin H, Chen X, Wu C, Hong X et al (2023) Exploring the key genomic variation in monkeypox virus during the 2022 outbreak. BMC Genom Data 24(1):67","journal-title":"BMC Genom Data"},{"issue":"8","key":"11421_CR63","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.chom.2022.07.001","volume":"30","author":"N Liu","year":"2022","unstructured":"Liu N, Xu Y, Li Q, Cao Y, Yang D, Liu S, Wang X, Mi Y, Liu Y, Ding C, Liu Y (2022) A lncRNA fine-tunes salicylic acid biosynthesis to balance plant immunity and growth. Cell Host Microbe 30(8):1124\u20131138","journal-title":"Cell Host Microbe"},{"issue":"1","key":"11421_CR64","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41392-023-01675-2","volume":"8","author":"J Lu","year":"2023","unstructured":"Lu J, Xing H, Wang C, Tang M, Wu C, Ye F et al (2023) Mpox (formerly monkeypox): pathogenesis, prevention, and treatment. Signal Transduct Target Ther 8(1):458","journal-title":"Signal Transduct Target Ther"},{"key":"11421_CR65","doi-asserted-by":"publisher","first-page":"1481452","DOI":"10.3389\/fpls.2024.1481452","volume":"15","author":"JA Melendez","year":"2024","unstructured":"Melendez JA, Sun H, Bonner J, Chen Q (2024) Characterization of a plant-derived monoclonal antibody targeting extracellular enveloped virions of Monkeypox virus. Front Plant Sci 15:1481452","journal-title":"Front Plant Sci"},{"issue":"Pt 4","key":"11421_CR66","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1099\/0022-1317-79-4-877","volume":"79","author":"A Vanderplasschen","year":"1998","unstructured":"Vanderplasschen A, Hollinshead M, Smith GL (1998) Intracellular and extracellular vaccinia virions enter cells by different mechanisms. J Gen Virol 79(Pt 4):877\u2013887","journal-title":"J Gen Virol"},{"key":"11421_CR67","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.semcdb.2016.07.015","volume":"60","author":"B Moss","year":"2016","unstructured":"Moss B (2016) Membrane fusion during poxvirus entry. Semin Cell Dev Biol 60:89\u201396","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"11421_CR68","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1128\/JVI.72.1.294-302.1998","volume":"72","author":"E Herrera","year":"1998","unstructured":"Herrera E, Lorenzo MM, Blasco R, Isaacs SN (1998) Functional analysis of vaccinia virus B5R protein: essential role in virus envelopment is independent of a large portion of the extracellular domain. J Virol 72(1):294\u2013302","journal-title":"J Virol"},{"issue":"1","key":"11421_CR69","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1128\/jvi.70.1.272-281.1996","volume":"70","author":"AA McIntosh","year":"1996","unstructured":"McIntosh AA, Smith GL (1996) Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus. J Virol 70(1):272\u2013281","journal-title":"J Virol"},{"issue":"10","key":"11421_CR70","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41577-022-00775-4","volume":"22","author":"F-M Lum","year":"2022","unstructured":"Lum F-M, Torres-Ruesta A, Tay MZ, Lin RTP, Lye DC, R\u00e9nia L et al (2022) Monkeypox: disease epidemiology, host immunity and clinical interventions. Nat Rev Immunol 22(10):597\u2013613","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"11421_CR71","doi-asserted-by":"publisher","first-page":"8750","DOI":"10.1128\/JVI.73.10.8750-8761.1999","volume":"73","author":"JC Hsiao","year":"1999","unstructured":"Hsiao JC, Chung CS, Chang W (1999) Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells. J Virol 73(10):8750\u20138761","journal-title":"J Virol"},{"issue":"2","key":"11421_CR72","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1128\/JVI.72.2.1577-1585.1998","volume":"72","author":"CS Chung","year":"1998","unstructured":"Chung CS, Hsiao JC, Chang YS, Chang W (1998) A27L protein mediates vaccinia virus interaction with cell surface heparan sulfate. J Virol 72(2):1577\u20131585","journal-title":"J Virol"},{"issue":"7","key":"11421_CR73","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1128\/JVI.74.7.3353-3365.2000","volume":"74","author":"CL Lin","year":"2000","unstructured":"Lin CL, Chung CS, Heine HG, Chang W (2000) Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo. J Virol 74(7):3353\u20133365","journal-title":"J Virol"},{"issue":"17","key":"11421_CR74","doi-asserted-by":"publisher","first-page":"8687","DOI":"10.1128\/JVI.00852-08","volume":"82","author":"H Bisht","year":"2008","unstructured":"Bisht H, Weisberg AS, Moss B (2008) Vaccinia virus l1 protein is required for cell entry and membrane fusion. J Virol 82(17):8687\u20138694","journal-title":"J Virol"},{"issue":"10","key":"11421_CR75","doi-asserted-by":"publisher","first-page":"6667","DOI":"10.1073\/pnas.062163799","volume":"99","author":"TG Senkevich","year":"2002","unstructured":"Senkevich TG, White CL, Koonin EV, Moss B (2002) Complete pathway for protein disulfide bond formation encoded by poxviruses. Proc Natl Acad Sci USA 99(10):6667\u20136672","journal-title":"Proc Natl Acad Sci USA"},{"key":"11421_CR76","doi-asserted-by":"publisher","first-page":"100330","DOI":"10.1016\/j.microb.2025.100330","volume":"7","author":"PA Barbhuiya","year":"2025","unstructured":"Barbhuiya PA, Laskar MA, Talukdar S, Kumari P, Pathak MP (2025) Current trends in diagnostics, biomarker identification, and drug discovery targeting Monkeypox (Mpox). Microbe 7:100330","journal-title":"Microbe"},{"issue":"2","key":"11421_CR77","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1006\/viro.2002.1446","volume":"297","author":"SN Shchelkunov","year":"2002","unstructured":"Shchelkunov SN, Totmenin AV, Safronov PF, Mikheev MV, Gutorov VV, Ryazankina OI et al (2002) Analysis of the monkeypox virus genome. Virology 297(2):172\u2013194","journal-title":"Virology"},{"key":"11421_CR78","doi-asserted-by":"publisher","first-page":"RP100545","DOI":"10.7554\/eLife.100545.3","volume":"13","author":"B Zheng","year":"2025","unstructured":"Zheng B, Duan M, Huang Y, Wang S, Qiu J, Lu Z et al (2025) Discovery of a heparan sulfate binding domain in monkeypox virus H3 as an anti-poxviral drug target combining AI and MD simulations. Elife 13:RP100545. https:\/\/doi.org\/10.7554\/eLife.100545.3","journal-title":"Elife"},{"issue":"5","key":"11421_CR79","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3390\/md21050264","volume":"21","author":"P He","year":"2023","unstructured":"He P, Shi D, Li Y, Xia K, Kim SB, Dwivedi R et al (2023) SPR sensor-based analysis of the inhibition of marine sulfated glycans on interactions between monkeypox virus proteins and glycosaminoglycans. Mar Drugs 21(5):264. https:\/\/doi.org\/10.3390\/md21050264","journal-title":"Mar Drugs"},{"issue":"1","key":"11421_CR80","doi-asserted-by":"publisher","first-page":"5925","DOI":"10.1038\/s41467-023-41628-5","volume":"14","author":"F Hou","year":"2023","unstructured":"Hou F, Zhang Y, Liu X, Murad YM, Xu J, Yu Z et al (2023) mRNA vaccines encoding fusion proteins of monkeypox virus antigens protect mice from vaccinia virus challenge. Nat Commun 14(1):5925","journal-title":"Nat Commun"},{"issue":"1","key":"11421_CR81","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1186\/s12879-025-10899-2","volume":"25","author":"R Hajjo","year":"2025","unstructured":"Hajjo R, Abusara OH, Sabbah DA, Bardaweel SK (2025) Advancing the understanding and management of Mpox: insights into epidemiology, disease pathways, prevention, and therapeutic strategies. BMC Infect Dis 25(1):529","journal-title":"BMC Infect Dis"},{"issue":"7","key":"11421_CR82","doi-asserted-by":"publisher","first-page":"947","DOI":"10.3390\/pathogens12070947","volume":"12","author":"DE Mart\u00ednez-Fern\u00e1ndez","year":"2023","unstructured":"Mart\u00ednez-Fern\u00e1ndez DE, Fern\u00e1ndez-Quezada D, Casillas-Mu\u00f1oz FAG, Carrillo-Ballesteros FJ, Ortega-Prieto AM, Jimenez-Guarde\u00f1o JM et al (2023) Human monkeypox: a comprehensive overview of epidemiology, pathogenesis, diagnosis, treatment, and prevention strategies. Pathogens 12(7):947. https:\/\/doi.org\/10.3390\/pathogens12070947","journal-title":"Pathogens"},{"issue":"10","key":"11421_CR83","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.3390\/v13102106","volume":"13","author":"ME Abernathy","year":"2021","unstructured":"Abernathy ME, Dam KMA, Esswein SR, Jette CA, Bjorkman PJ (2021) How antibodies recognize pathogenic viruses: structural correlates of antibody neutralization of HIV-1, SARS-CoV-2, and Zika. Viruses 13(10):2106","journal-title":"Viruses"},{"issue":"23","key":"11421_CR84","doi-asserted-by":"publisher","first-page":"4398","DOI":"10.1016\/j.molcel.2023.10.038","volume":"83","author":"X Wang","year":"2023","unstructured":"Wang X, Ma L, Li N, Gao N (2023) Structural insights into the assembly and mechanism of mpox virus DNA polymerase complex F8-A22-E4-H5. Mol Cell 83(23):4398\u2013412.e4","journal-title":"Mol Cell"},{"issue":"6","key":"11421_CR85","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41422-023-00796-1","volume":"33","author":"Y Xu","year":"2023","unstructured":"Xu Y, Wu Y, Zhang Y, Fan R, Yang Y, Li D et al (2023) Cryo-EM structures of human monkeypox viral replication complexes with and without DNA duplex. Cell Res 33(6):479\u2013482","journal-title":"Cell Res"},{"issue":"3","key":"11421_CR86","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrmicro1099","volume":"3","author":"G McFadden","year":"2005","unstructured":"McFadden G (2005) Poxvirus tropism. Nat Rev Microbiol 3(3):201\u2013213","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"11421_CR87","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.cell.2012.05.049","volume":"150","author":"NC Elde","year":"2012","unstructured":"Elde NC, Child SJ, Eickbush MT, Kitzman JO, Rogers KS, Shendure J et al (2012) Poxviruses deploy genomic accordions to adapt rapidly against host antiviral defenses. Cell 150(4):831\u2013841","journal-title":"Cell"},{"key":"11421_CR88","doi-asserted-by":"publisher","first-page":"1414224","DOI":"10.3389\/fcimb.2024.1414224","volume":"14","author":"K Sagdat","year":"2024","unstructured":"Sagdat K, Batyrkhan A, Kanayeva D (2024) Exploring monkeypox virus proteins and rapid detection techniques. Front Cell Infect Microbiol 14:1414224","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"11421_CR89","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41421-025-00771-7","volume":"11","author":"X Yang","year":"2025","unstructured":"Yang X, Guo L, Duan H, Fan M, Xu F, Chi X et al (2025) Identification of neutralizing nanobodies protecting against poxvirus infection. Cell Discov 11(1):31","journal-title":"Cell Discov"},{"key":"11421_CR90","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02154-17","author":"P Bryk","year":"2018","unstructured":"Bryk P, Brewer MG, Ward BM (2018) Vaccinia virus phospholipase protein F13 promotes rapid entry of extracellular virions into cells. J Virol. https:\/\/doi.org\/10.1128\/JVI.02154-17","journal-title":"J Virol"},{"issue":"2","key":"11421_CR91","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.virusres.2004.08.015","volume":"106","author":"GL Smith","year":"2004","unstructured":"Smith GL, Law M (2004) The exit of Vaccinia virus from infected cells. Virus Res 106(2):189\u2013197","journal-title":"Virus Res"},{"issue":"3","key":"11421_CR92","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s41564-025-01936-6","volume":"10","author":"R Vernuccio","year":"2025","unstructured":"Vernuccio R, Mart\u00ednez Le\u00f3n A, Poojari CS, Buchrieser J, Selverian CN, Jaleta Y et al (2025) Structural insights into tecovirimat antiviral activity and poxvirus resistance. Nat Microbiol 10(3):734\u2013748","journal-title":"Nat Microbiol"},{"issue":"10","key":"11421_CR93","doi-asserted-by":"publisher","first-page":"6639","DOI":"10.1074\/jbc.M114.547372","volume":"289","author":"D-R Wang","year":"2014","unstructured":"Wang D-R, Hsiao J-C, Wong C-H, Li G-C, Lin S-C, Yu SSF et al (2014) Vaccinia viral protein A27 is anchored to the viral membrane via a cooperative interaction with viral membrane protein A17*. J Biol Chem 289(10):6639\u20136655","journal-title":"J Biol Chem"},{"issue":"23","key":"11421_CR94","doi-asserted-by":"publisher","first-page":"20949","DOI":"10.1074\/jbc.M110403200","volume":"277","author":"TH Lin","year":"2002","unstructured":"Lin TH, Chia CM, Hsiao JC, Chang W, Ku CC, Hung SC et al (2002) Structural analysis of the extracellular domain of vaccinia virus envelope protein, A27L, by NMR and CD spectroscopy. J Biol Chem 277(23):20949\u201320959","journal-title":"J Biol Chem"},{"issue":"1","key":"11421_CR95","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1743-422X-2-91","volume":"2","author":"RE Blouch","year":"2005","unstructured":"Blouch RE, Byrd CM, Hruby DE (2005) Importance of disulphide bonds for vaccinia virus L1R protein function. Virol J 2(1):91","journal-title":"Virol J"},{"issue":"27-28","key":"11421_CR96","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1016\/j.vaccine.2008.04.017","volume":"26","author":"JW Golden","year":"2008","unstructured":"Golden JW, Josleyn MD, Hooper JW (2008) Targeting the vaccinia virus L1 protein to the cell surface enhances production of neutralizing antibodies. Vaccine 26(27\u201328):3507\u20133515","journal-title":"Vaccine"},{"issue":"9","key":"11421_CR97","doi-asserted-by":"publisher","first-page":"e1005148","DOI":"10.1371\/journal.ppat.1005148","volume":"11","author":"MH Matho","year":"2015","unstructured":"Matho MH, Schlossman A, Meng X, Benhnia MR, Kaever T, Buller M et al (2015) Structural and functional characterization of anti-A33 antibodies reveal a potent cross-species orthopoxviruses neutralizer. PLoS Pathog 11(9):e1005148","journal-title":"PLoS Pathog"},{"issue":"6","key":"11421_CR98","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1128\/MCB.24.6.2444-2454.2004","volume":"24","author":"E Ainbinder","year":"2004","unstructured":"Ainbinder E, Amir-Zilberstein L, Yamaguchi Y, Handa H, Dikstein R (2004) Elongation inhibition by DRB sensitivity-inducing factor is regulated by the A20 promoter via a novel negative element and NF-kappaB. Mol Cell Biol 24(6):2444\u20132454","journal-title":"Mol Cell Biol"},{"issue":"2","key":"11421_CR99","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.antiviral.2012.02.012","volume":"94","author":"MN Prichard","year":"2012","unstructured":"Prichard MN, Kern ER (2012) Orthopoxvirus targets for the development of new antiviral agents. Antiviral Res 94(2):111\u2013125","journal-title":"Antiviral Res"},{"issue":"3","key":"11421_CR100","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1586\/erv.10.5","volume":"9","author":"N Paran","year":"2010","unstructured":"Paran N, Lustig S (2010) Complement-bound human antibodies to vaccinia virus B5 antigen protect mice from virus challenge. Expert Rev Vaccines 9(3):255\u2013259","journal-title":"Expert Rev Vaccines"},{"key":"11421_CR101","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.virusres.2017.01.027","volume":"234","author":"MW Czarnecki","year":"2017","unstructured":"Czarnecki MW, Traktman P (2017) The vaccinia virus DNA polymerase and its processivity factor. Virus Res 234:193\u2013206","journal-title":"Virus Res"},{"issue":"1","key":"11421_CR102","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1128\/AAC.01601-13","volume":"58","author":"S Duraffour","year":"2014","unstructured":"Duraffour S, Drillien R, Haraguchi K, Balzarini J, Topalis D, van den Oord JJ, Andrei G, Snoeck R (2014) KAY-2-41, a novel nucleoside analogue inhibitor of orthopoxviruses in vitro and in vivo. Antimicrob Agents Chemother 58(1):27\u201337","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"11421_CR103","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1128\/CMR.00102-15","volume":"29","author":"E De Clercq","year":"2016","unstructured":"De Clercq E, Li G (2016) Approved antiviral drugs over the past 50 years. Clin Microbiol Rev 29(3):695\u2013747","journal-title":"Clin Microbiol Rev"},{"issue":"6627","key":"11421_CR104","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1126\/science.ade6360","volume":"379","author":"Q Peng","year":"2023","unstructured":"Peng Q, Xie Y, Kuai L, Wang H, Qi J, Gao GF et al (2023) Structure of monkeypox virus DNA polymerase holoenzyme. Science 379(6627):100\u2013105","journal-title":"Science"},{"key":"11421_CR105","doi-asserted-by":"publisher","first-page":"105995","DOI":"10.1016\/j.antiviral.2024.105995","volume":"231","author":"J Pr\u00e9vost","year":"2024","unstructured":"Pr\u00e9vost J, Sloan A, Deschambault Y, Tailor N, Tierney K, Azaransky K et al (2024) Treatment efficacy of cidofovir and brincidofovir against clade II Monkeypox virus isolates. Antiviral Res 231:105995","journal-title":"Antiviral Res"},{"issue":"1","key":"11421_CR106","doi-asserted-by":"publisher","first-page":"13007","DOI":"10.1038\/s41598-022-16999-2","volume":"12","author":"S Tonnemacher","year":"2022","unstructured":"Tonnemacher S, Folly-Klan M, Gazi AD, Sch\u00e4fer S, P\u00e9nard E, Eberle R et al (2022) Vaccinia virus H7-protein is required for the organization of the viral scaffold protein into hexamers. Sci Rep 12(1):13007","journal-title":"Sci Rep"},{"issue":"7","key":"11421_CR107","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.str.2011.03.023","volume":"19","author":"MW Bahar","year":"2011","unstructured":"Bahar MW, Graham SC, Stuart DI, Grimes JM (2011) Insights into the evolution of a complex virus from the crystal structure of vaccinia virus D13. Structure 19(7):1011\u20131020","journal-title":"Structure"},{"issue":"1","key":"11421_CR108","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/1743-422X-6-188","volume":"6","author":"A Alkhalil","year":"2009","unstructured":"Alkhalil A, Strand S, Mucker E, Huggins JW, Jahrling PB, Ibrahim SM (2009) Inhibition of Monkeypox virus replication by RNA interference. Virol J 6(1):188","journal-title":"Virol J"},{"issue":"2","key":"11421_CR109","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.virol.2007.02.016","volume":"363","author":"SG Cresawn","year":"2007","unstructured":"Cresawn SG, Condit RC (2007) A targeted approach to identification of vaccinia virus postreplicative transcription elongation factors: genetic evidence for a role of the H5R gene in vaccinia transcription. Virology 363(2):333\u2013341","journal-title":"Virology"},{"issue":"4","key":"11421_CR110","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1084\/jem.20071854","volume":"205","author":"R-H Xu","year":"2008","unstructured":"Xu R-H, Cohen M, Tang Y, Lazear E, Whitbeck JC, Eisenberg RJ et al (2008) The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccination. J Exp Med 205(4):981\u2013992","journal-title":"J Exp Med"},{"issue":"1","key":"11421_CR111","doi-asserted-by":"publisher","first-page":"7267","DOI":"10.1038\/s41467-024-51498-0","volume":"15","author":"Z Taha","year":"2024","unstructured":"Taha Z, Crupi MJF, Alluqmani N, MacKenzie D, Vallati S, Whelan JT et al (2024) Complementary dual-virus strategy drives synthetic target and cognate T-cell engager expression for endogenous-antigen agnostic immunotherapy. Nat Commun 15(1):7267","journal-title":"Nat Commun"},{"issue":"10","key":"11421_CR112","doi-asserted-by":"publisher","first-page":"e2411686122","DOI":"10.1073\/pnas.2411686122","volume":"122","author":"Y Xie","year":"2025","unstructured":"Xie Y, Kuai L, Peng Q, Wang Q, Wang H, Li X et al (2025) Structural basis of DNA replication fidelity of the Mpox virus. Proc Natl Acad Sci USA 122(10):e2411686122","journal-title":"Proc Natl Acad Sci USA"},{"issue":"20","key":"11421_CR113","doi-asserted-by":"publisher","first-page":"10083","DOI":"10.1128\/JVI.00607-06","volume":"80","author":"JO Langland","year":"2006","unstructured":"Langland JO, Kash JC, Carter V, Thomas MJ, Katze MG, Jacobs BL (2006) Suppression of proinflammatory signal transduction and gene expression by the dualNucleic acid binding domains of the vaccinia virus E3L proteins. J Virol 80(20):10083\u201310095","journal-title":"J Virol"},{"issue":"1","key":"11421_CR114","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41594-023-01142-0","volume":"31","author":"Y Li","year":"2024","unstructured":"Li Y, Zhu J, Guo Y, Yan R (2024) Structural insight into the assembly and working mechanism of helicase-primase D5 from Mpox virus. Nat Struct Mol Biol 31(1):68\u201381","journal-title":"Nat Struct Mol Biol"},{"issue":"34","key":"11421_CR115","doi-asserted-by":"publisher","first-page":"eadl1150","DOI":"10.1126\/sciadv.adl1150","volume":"10","author":"Y Xu","year":"2024","unstructured":"Xu Y, Wu Y, Zhang Y, Gao K, Wu X, Yang Y et al (2024) Essential and multifunctional mpox virus E5 helicase-primase in double and single hexamer. Sci Adv 10(34):eadl1150","journal-title":"Sci Adv"},{"key":"11421_CR116","unstructured":"Fischer U, Bartuli J, Grimm C (2021) Chapter one\u2014structure and function of the poxvirus transcription machinery. In: Cameron CE, Arnold JJ, Kaguni LS (eds) The enzymes, vol 50. Academic Press, pp 1\u201320"},{"issue":"5","key":"11421_CR117","doi-asserted-by":"publisher","first-page":"395","DOI":"10.33594\/000000665","volume":"57","author":"V Pandey","year":"2023","unstructured":"Pandey V, Punniyamoorthy S, Pokharel YR (2023) Emerging roles of SPT5 in transcription. Cell Physiol Biochem 57(5):395\u2013408","journal-title":"Cell Physiol Biochem"},{"key":"11421_CR118","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.virol.2014.06.039","volume":"464\u2013465","author":"LJ Hughes","year":"2014","unstructured":"Hughes LJ, Goldstein J, Pohl J, Hooper JW, Lee Pitts R, Townsend MB et al (2014) A highly specific monoclonal antibody against monkeypox virus detects the heparin binding domain of A27. Virology 464\u2013465:264\u2013273","journal-title":"Virology"},{"issue":"27","key":"11421_CR119","doi-asserted-by":"publisher","first-page":"15974","DOI":"10.1074\/jbc.270.27.15974","volume":"270","author":"OR Colamonici","year":"1995","unstructured":"Colamonici OR, Domanski P, Sweitzer SM, Larner A, Buller RML (1995) Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon \u03b1 transmembrane signaling (\u2217). J Biol Chem 270(27):15974\u201315978","journal-title":"J Biol Chem"},{"issue":"12","key":"11421_CR120","doi-asserted-by":"publisher","first-page":"e0189308","DOI":"10.1371\/journal.pone.0189308","volume":"12","author":"YG Kim","year":"2017","unstructured":"Kim YG, Baltabekova AZ, Zhiyenbay EE, Aksambayeva AS, Shagyrova ZS, Khannanov R et al (2017) Recombinant vaccinia virus-coded interferon inhibitor B18R: expression, refolding and a use in a mammalian expression system with a RNA-vector. PLoS ONE 12(12):e0189308","journal-title":"PLoS ONE"},{"issue":"7","key":"11421_CR121","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1089\/jir.2013.0072","volume":"34","author":"C Fritz-French","year":"2014","unstructured":"Fritz-French C, Shawahna R, Ward JE, Maroun LE, Tyor WR (2014) The recombinant vaccinia virus gene product, B18R, neutralizes interferon alpha and alleviates histopathological complications in an HIV encephalitis mouse model. J Interferon Cytokine Res 34(7):510\u2013517","journal-title":"J Interferon Cytokine Res"},{"issue":"23","key":"11421_CR122","doi-asserted-by":"publisher","first-page":"11230","DOI":"10.1128\/JVI.74.23.11230-11239.2000","volume":"74","author":"A Alcam\u00ed","year":"2000","unstructured":"Alcam\u00ed A, Symons JA, Smith GL (2000) The vaccinia virus soluble alpha\/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN. J Virol 74(23):11230\u201311239","journal-title":"J Virol"},{"issue":"18","key":"11421_CR123","doi-asserted-by":"publisher","first-page":"9960","DOI":"10.1128\/JVI.77.18.9960-9968.2003","volume":"77","author":"PC Reading","year":"2003","unstructured":"Reading PC, Smith GL (2003) Vaccinia virus interleukin-18-binding protein promotes virulence by reducing gamma interferon production and natural killer and T-cell activity. J Virol 77(18):9960\u20139968","journal-title":"J Virol"},{"issue":"Pt 11","key":"11421_CR124","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1099\/0022-1317-83-11-2833","volume":"83","author":"JA Symons","year":"2002","unstructured":"Symons JA, Adams E, Tscharke DC, Reading PC, Waldmann H, Smith GL (2002) The vaccinia virus C12L protein inhibits mouse IL-18 and promotes virus virulence in the murine intranasal model. J Gen Virol 83(Pt 11):2833\u20132844","journal-title":"J Gen Virol"},{"issue":"1","key":"11421_CR125","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/nyas.14000","volume":"1438","author":"C Park","year":"2019","unstructured":"Park C, Peng C, Brennan G, Rothenburg S (2019) Species-specific inhibition of antiviral protein kinase R by capripoxviruses and vaccinia virus. Ann NY Acad Sci 1438(1):18\u201329","journal-title":"Ann NY Acad Sci"},{"key":"11421_CR126","doi-asserted-by":"publisher","first-page":"RP99575","DOI":"10.7554\/eLife.99575","volume":"13","author":"MJ Chambers","year":"2024","unstructured":"Chambers MJ, Scobell SB, Sadhu MJ (2024) Systematic genetic characterization of the human PKR kinase domain highlights its functional malleability to escape a poxvirus substrate mimic. Elife 13:RP99575","journal-title":"Elife"},{"issue":"5","key":"11421_CR127","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.virs.2024.08.008","volume":"39","author":"D Fang","year":"2024","unstructured":"Fang D, Liu Y, Dou D, Su B (2024) The unique immune evasion mechanisms of the mpox virus and their implication for developing new vaccines and immunotherapies. Virol Sin 39(5):709\u2013718","journal-title":"Virol Sin"},{"key":"11421_CR128","doi-asserted-by":"publisher","first-page":"1354410","DOI":"10.3389\/fcimb.2024.1354410","volume":"14","author":"Y Wang","year":"2024","unstructured":"Wang Y, Zhang J, Li M, Jia M, Yang L, Wang T et al (2024) Transcriptome and proteomic analysis of mpox virus F3L-expressing cells. Front Cell Infect Microbiol 14:1354410","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"11421_CR129","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1128\/JVI.01948-12","volume":"87","author":"E Lazear","year":"2013","unstructured":"Lazear E, Peterson LW, Nelson CA, Fremont DH (2013) Crystal structure of the cowpox virus-encoded NKG2D ligand OMCP. J Virol 87(2):840\u2013850","journal-title":"J Virol"},{"key":"11421_CR130","volume-title":"Advances in antiviral therapies: exploring amphiphilic small molecules for Mpox virus treatment","author":"A Hussain","year":"2025","unstructured":"Hussain A, Hussain A (2025) Advances in antiviral therapies: exploring amphiphilic small molecules for Mpox virus treatment. Bentham Science Publishers"},{"issue":"1","key":"11421_CR131","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s40259-016-0158-5","volume":"30","author":"GA Shchelkunova","year":"2016","unstructured":"Shchelkunova GA, Shchelkunov SN (2016) Immunomodulating drugs based on poxviral proteins. BioDrugs 30(1):9\u201316","journal-title":"BioDrugs"},{"issue":"44","key":"11421_CR132","doi-asserted-by":"publisher","first-page":"16900","DOI":"10.1073\/pnas.0804525105","volume":"105","author":"C Caillat","year":"2008","unstructured":"Caillat C, Topalis D, Agrofoglio LA, Pochet S, Balzarini J, Deville-Bonne D et al (2008) Crystal structure of poxvirus thymidylate kinase: an unexpected dimerization has implications for antiviral therapy. Proc Natl Acad Sci USA 105(44):16900\u201316905","journal-title":"Proc Natl Acad Sci USA"},{"key":"11421_CR133","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27165277","author":"HYI Lam","year":"2022","unstructured":"Lam HYI, Guan JS, Mu Y (2022) In silico repurposed drugs against monkeypox virus. Molecules. https:\/\/doi.org\/10.3390\/molecules27165277","journal-title":"Molecules"},{"issue":"1","key":"11421_CR134","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nsmb.1529","volume":"16","author":"S Rothenburg","year":"2009","unstructured":"Rothenburg S, Seo EJ, Gibbs JS, Dever TE, Dittmar K (2009) Rapid evolution of protein kinase PKR alters sensitivity to viral inhibitors. Nat Struct Mol Biol 16(1):63\u201370","journal-title":"Nat Struct Mol Biol"},{"issue":"2","key":"11421_CR135","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S1097-2765(02)00590-7","volume":"10","author":"AC Dar","year":"2002","unstructured":"Dar AC, Sicheri F (2002) X-ray crystal structure and functional analysis of vaccinia virus K3L reveals molecular determinants for PKR subversion and substrate recognition. Mol Cell 10(2):295\u2013305","journal-title":"Mol Cell"},{"issue":"1","key":"11421_CR136","doi-asserted-by":"publisher","first-page":"e1009183","DOI":"10.1371\/journal.ppat.1009183","volume":"17","author":"C Park","year":"2021","unstructured":"Park C, Peng C, Rahman MJ, Haller SL, Tazi L, Brennan G et al (2021) Orthopoxvirus K3 orthologs show virus- and host-specific inhibition of the antiviral protein kinase PKR. PLoS Pathog 17(1):e1009183","journal-title":"PLoS Pathog"},{"issue":"4","key":"11421_CR137","doi-asserted-by":"publisher","first-page":"e3000217","DOI":"10.1371\/journal.pbio.3000217","volume":"17","author":"CJ Warren","year":"2019","unstructured":"Warren CJ, Sawyer SL (2019) How host genetics dictates successful viral zoonosis. PLoS Biol 17(4):e3000217","journal-title":"PLoS Biol"},{"key":"11421_CR138","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0065-3527(06)66002-8","volume":"66","author":"RC Condit","year":"2006","unstructured":"Condit RC, Moussatche N, Traktman P (2006) In a nutshell: structure and assembly of the vaccinia virion. Adv Virus Res 66:31\u2013124","journal-title":"Adv Virus Res"},{"issue":"12","key":"11421_CR139","doi-asserted-by":"publisher","first-page":"e1002446","DOI":"10.1371\/journal.ppat.1002446","volume":"7","author":"JP Laliberte","year":"2011","unstructured":"Laliberte JP, Weisberg AS, Moss B (2011) The membrane fusion step of vaccinia virus entry is cooperatively mediated by multiple viral proteins and host cell components. PLoS Pathog 7(12):e1002446","journal-title":"PLoS Pathog"},{"issue":"17","key":"11421_CR140","doi-asserted-by":"publisher","first-page":"8422","DOI":"10.1128\/JVI.00599-10","volume":"84","author":"SJ Chang","year":"2010","unstructured":"Chang SJ, Chang YX, Izmailyan R, Tang YL, Chang W (2010) Vaccinia virus A25 and A26 proteins are fusion suppressors for mature virions and determine strain-specific virus entry pathways into HeLa, CHO-K1, and L cells. J Virol 84(17):8422\u20138432","journal-title":"J Virol"},{"issue":"5","key":"11421_CR141","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1128\/JVI.80.5.2127-2140.2006","volume":"80","author":"CS Chung","year":"2006","unstructured":"Chung CS, Chen CH, Ho MY, Huang CY, Liao CL, Chang W (2006) Vaccinia virus proteome: identification of proteins in vaccinia virus intracellular mature virion particles. J Virol 80(5):2127\u20132140","journal-title":"J Virol"},{"issue":"3","key":"11421_CR142","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.celrep.2013.06.028","volume":"4","author":"FI Schmidt","year":"2013","unstructured":"Schmidt FI, Bleck CK, Reh L, Novy K, Wollscheid B, Helenius A et al (2013) Vaccinia virus entry is followed by core activation and proteasome-mediated release of the immunomodulatory effector VH1 from lateral bodies. Cell Rep 4(3):464\u2013476","journal-title":"Cell Rep"},{"issue":"12","key":"11421_CR143","doi-asserted-by":"publisher","first-page":"e79953","DOI":"10.1371\/journal.pone.0079953","volume":"8","author":"PW Dabrowski","year":"2013","unstructured":"Dabrowski PW, Radoni\u0107 A, Kurth A, Nitsche A (2013) Genome-wide comparison of cowpox viruses reveals a new clade related to Variola virus. PLoS ONE 8(12):e79953","journal-title":"PLoS ONE"},{"issue":"28","key":"11421_CR144","doi-asserted-by":"publisher","first-page":"24702","DOI":"10.1074\/jbc.M111.222216","volume":"286","author":"KA Boyle","year":"2011","unstructured":"Boyle KA, Stanitsa ES, Greseth MD, Lindgren JK, Traktman P (2011) Evaluation of the role of the vaccinia virus uracil DNA glycosylase and A20 proteins as intrinsic components of the DNA polymerase holoenzyme. J Biol Chem 286(28):24702\u201324713","journal-title":"J Biol Chem"},{"issue":"23","key":"11421_CR145","doi-asserted-by":"publisher","first-page":"12325","DOI":"10.1128\/JVI.01435-10","volume":"84","author":"AM Druck Shudofsky","year":"2010","unstructured":"Druck Shudofsky AM, Silverman JE, Chattopadhyay D, Ricciardi RP (2010) Vaccinia virus D4 mutants defective in processive DNA synthesis retain binding to A20 and DNA. J Virol 84(23):12325\u201312335","journal-title":"J Virol"},{"issue":"6","key":"11421_CR146","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1074\/jbc.M511239200","volume":"281","author":"ES Stanitsa","year":"2006","unstructured":"Stanitsa ES, Arps L, Traktman P (2006) Vaccinia virus uracil DNA glycosylase interacts with the A20 protein to form a heterodimeric processivity factor for the viral DNA polymerase. J Biol Chem 281(6):3439\u20133451","journal-title":"J Biol Chem"},{"issue":"53","key":"11421_CR147","doi-asserted-by":"publisher","first-page":"27087","DOI":"10.1074\/jbc.M116.761908","volume":"291","author":"M Nuth","year":"2016","unstructured":"Nuth M, Guan H, Ricciardi RP (2016) A conserved tripeptide sequence at the C terminus of the Poxvirus DNA processivity factor D4 is essential for protein integrity and function. J Biol Chem 291(53):27087\u201327097","journal-title":"J Biol Chem"},{"issue":"1","key":"11421_CR148","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrm2308","volume":"9","author":"RJ Youle","year":"2008","unstructured":"Youle RJ, Strasser A (2008) The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9(1):47\u201359","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"11421_CR149","doi-asserted-by":"publisher","first-page":"e909","DOI":"10.1038\/cddis.2013.436","volume":"4","author":"M Kvansakul","year":"2013","unstructured":"Kvansakul M, Hinds MG (2013) Structural biology of the Bcl-2 family and its mimicry by viral proteins. Cell Death Dis 4(11):e909","journal-title":"Cell Death Dis"},{"issue":"15","key":"11421_CR150","doi-asserted-by":"publisher","first-page":"8667","DOI":"10.1128\/JVI.01092-14","volume":"88","author":"S Campbell","year":"2014","unstructured":"Campbell S, Thibault J, Mehta N, Colman PM, Barry M, Kvansakul M (2014) Structural insight into BH3 domain binding of vaccinia virus antiapoptotic F1L. J Virol 88(15):8667\u20138677","journal-title":"J Virol"},{"issue":"3","key":"11421_CR151","doi-asserted-by":"publisher","first-page":"e1680","DOI":"10.1038\/cddis.2015.52","volume":"6","author":"B Marshall","year":"2015","unstructured":"Marshall B, Puthalakath H, Caria S, Chugh S, Doerflinger M, Colman PM et al (2015) Variola virus F1L is a Bcl-2-like protein that unlike its vaccinia virus counterpart inhibits apoptosis independent of Bim. Cell Death Dis 6(3):e1680","journal-title":"Cell Death Dis"},{"issue":"3","key":"11421_CR152","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.bj.2021.07.004","volume":"45","author":"LE Stark","year":"2022","unstructured":"Stark LE, Guan W, Colvin ME, LiWang PJ (2022) The binding and specificity of chemokine binding proteins, through the lens of experiment and computation. Biomed J 45(3):439\u2013453","journal-title":"Biomed J"},{"issue":"Pt 9","key":"11421_CR153","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1099\/0022-1317-82-9-2095","volume":"82","author":"A Ng","year":"2001","unstructured":"Ng A, Tscharke DC, Reading PC, Smith GL (2001) The vaccinia virus A41L protein is a soluble 30 kDa glycoprotein that affects virus virulence. J Gen Virol 82(Pt 9):2095\u20132105","journal-title":"J Gen Virol"},{"issue":"Pt 1","key":"11421_CR154","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1099\/vir.0.81417-0","volume":"87","author":"RH Clark","year":"2006","unstructured":"Clark RH, Kenyon JC, Bartlett NW, Tscharke DC, Smith GL (2006) Deletion of gene A41L enhances vaccinia virus immunogenicity and vaccine efficacy. J Gen Virol 87(Pt 1):29\u201338","journal-title":"J Gen Virol"},{"issue":"1","key":"11421_CR155","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1371\/journal.ppat.0040005","volume":"4","author":"MW Bahar","year":"2008","unstructured":"Bahar MW, Kenyon JC, Putz MM, Abrescia NG, Pease JE, Wise EL et al (2008) Structure and function of A41, a vaccinia virus chemokine binding protein. PLoS Pathog 4(1):e5","journal-title":"PLoS Pathog"},{"issue":"3","key":"11421_CR156","doi-asserted-by":"publisher","first-page":"716","DOI":"10.47108\/jidhealth.Vol5.Iss3.231","volume":"5","author":"AM Lazar","year":"2022","unstructured":"Lazar AM (2022) Monkeypox in the COVID-19 era. J Ideas Health 5(3):716\u2013724","journal-title":"J Ideas Health"},{"issue":"2","key":"11421_CR157","doi-asserted-by":"publisher","first-page":"447s","DOI":"10.1093\/ajcn\/83.2.447S","volume":"83","author":"CA Dinarello","year":"2006","unstructured":"Dinarello CA (2006) Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process. Am J Clin Nutr 83(2):447s-s455","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"11421_CR158","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.virol.2006.08.019","volume":"358","author":"X Meng","year":"2007","unstructured":"Meng X, Leman M, Xiang Y (2007) Variola virus IL-18 binding protein interacts with three human IL-18 residues that are part of a binding site for human IL-18 receptor alpha subunit. Virology 358(1):211\u2013220","journal-title":"Virology"},{"issue":"52","key":"11421_CR159","doi-asserted-by":"publisher","first-page":"20711","DOI":"10.1073\/pnas.0809086106","volume":"105","author":"B Krumm","year":"2008","unstructured":"Krumm B, Meng X, Li Y, Xiang Y, Deng J (2008) Structural basis for antagonism of human interleukin 18 by poxvirus interleukin 18-binding protein. Proc Natl Acad Sci USA 105(52):20711\u201320715","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"11421_CR160","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.4049\/jimmunol.171.3.1164","volume":"171","author":"T Plitz","year":"2003","unstructured":"Plitz T, Saint-M\u00e9zard P, Satho M, Herren S, Waltzinger C, de Carvalho Bittencourt M et al (2003) IL-18 binding protein protects against contact hypersensitivity. J Immunol 171(3):1164\u20131171","journal-title":"J Immunol"},{"issue":"33","key":"11421_CR161","doi-asserted-by":"publisher","first-page":"8424","DOI":"10.1073\/pnas.1810398115","volume":"115","author":"D Garriga","year":"2018","unstructured":"Garriga D, Headey S, Accurso C, Gunzburg M, Scanlon M, Coulibaly F (2018) Structural basis for the inhibition of poxvirus assembly by the antibiotic rifampicin. Proc Natl Acad Sci USA 115(33):8424\u20138429","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5191","key":"11421_CR162","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/222341a0","volume":"222","author":"JH Subak-Sharpe","year":"1969","unstructured":"Subak-Sharpe JH, Timbury MC, Williams JF (1969) Rifampicin inhibits the growth of some mammalian viruses. Nature 222(5191):341\u2013345","journal-title":"Nature"},{"issue":"1","key":"11421_CR163","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.virol.2006.09.031","volume":"359","author":"JC Charity","year":"2007","unstructured":"Charity JC, Katz E, Moss B (2007) Amino acid substitutions at multiple sites within the vaccinia virus D13 scaffold protein confer resistance to rifampicin. Virology 359(1):227\u2013232","journal-title":"Virology"},{"issue":"3","key":"11421_CR164","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1128\/AAC.2.3.181","volume":"2","author":"B Moss","year":"1972","unstructured":"Moss B, Rosenblum EN, Grimley PM, Mims SJ (1972) Rifamycins: modulation of specific anti-poxviral activity by small substitutions on the piperazinyliminomethyl side chain. Antimicrob Agents Chemother 2(3):181\u2013185","journal-title":"Antimicrob Agents Chemother"},{"issue":"24","key":"11421_CR165","doi-asserted-by":"publisher","first-page":"12298","DOI":"10.1128\/JVI.75.24.12298-12307.2001","volume":"75","author":"N Klemperer","year":"2001","unstructured":"Klemperer N, McDonald W, Boyle K, Unger B, Traktman P (2001) The A20R protein is a stoichiometric component of the processive form of vaccinia virus DNA polymerase. J Virol 75(24):12298\u201312307","journal-title":"J Virol"},{"issue":"2","key":"11421_CR166","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1006\/viro.2002.1721","volume":"303","author":"K Ishii","year":"2002","unstructured":"Ishii K, Moss B (2002) Mapping interaction sites of the A20R protein component of the vaccinia virus DNA replication complex. Virology 303(2):232\u2013239","journal-title":"Virology"},{"issue":"17","key":"11421_CR167","doi-asserted-by":"publisher","first-page":"8973","DOI":"10.1128\/JVI.76.17.8973-8976.2002","volume":"76","author":"CM Byrd","year":"2002","unstructured":"Byrd CM, Bolken TC, Hruby DE (2002) The vaccinia virus I7L gene product is the core protein proteinase. J Virol 76(17):8973\u20138976","journal-title":"J Virol"},{"key":"11421_CR168","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/bs.enz.2021.09.004","volume":"50","author":"J Zephyr","year":"2021","unstructured":"Zephyr J, Kurt Yilmaz N, Schiffer CA (2021) Viral proteases: structure, mechanism and inhibition. Enzymes 50:301\u2013333","journal-title":"Enzymes"},{"issue":"3","key":"11421_CR169","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2174\/156802610790725470","volume":"10","author":"H Steuber","year":"2010","unstructured":"Steuber H, Hilgenfeld R (2010) Recent advances in targeting viral proteases for the discovery of novel antivirals. Curr Top Med Chem 10(3):323\u2013345","journal-title":"Curr Top Med Chem"},{"issue":"22","key":"11421_CR170","doi-asserted-by":"publisher","first-page":"12147","DOI":"10.1128\/JVI.78.22.12147-12156.2004","volume":"78","author":"CM Byrd","year":"2004","unstructured":"Byrd CM, Bolken TC, Mjalli AM, Arimilli MN, Andrews RC, Rothlein R et al (2004) New class of orthopoxvirus antiviral drugs that block viral maturation. J Virol 78(22):12147\u201312156","journal-title":"J Virol"},{"issue":"11","key":"11421_CR171","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.3390\/v2112409","volume":"2","author":"R Jordan","year":"2010","unstructured":"Jordan R, Leeds JM, Tyavanagimatt S, Hruby DE (2010) Development of ST-246\u00ae for treatment of poxvirus infections. Viruses 2(11):2409\u20132435","journal-title":"Viruses"},{"issue":"Pt A","key":"11421_CR172","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1016\/j.ijbiomac.2022.11.145","volume":"223","author":"H Duan","year":"2022","unstructured":"Duan H, Hu K, Zheng D, Cheng Y, Zhang Z, Wang Y et al (2022) Recognition and release of uridine and hCNT3: From multivariate interactions to molecular design. Int J Biol Macromol 223(Pt A):1562\u20131577","journal-title":"Int J Biol Macromol"},{"issue":"1-2","key":"11421_CR173","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0166-3542(02)00199-7","volume":"57","author":"DF Smee","year":"2003","unstructured":"Smee DF, Sidwell RW (2003) A review of compounds exhibiting anti-orthopoxvirus activity in animal models. Antivir Res 57(1\u20132):41\u201352","journal-title":"Antivir Res"},{"issue":"24","key":"11421_CR174","doi-asserted-by":"publisher","first-page":"13392","DOI":"10.1128\/JVI.00770-07","volume":"81","author":"L Deng","year":"2007","unstructured":"Deng L, Dai P, Ciro A, Smee DF, Djaballah H, Shuman S (2007) Identification of novel antipoxviral agents: mitoxantrone inhibits vaccinia virus replication by blocking virion assembly. J Virol 81(24):13392\u201313402","journal-title":"J Virol"},{"issue":"12","key":"11421_CR175","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.3201\/eid2912.231146","volume":"29","author":"TG Smith","year":"2023","unstructured":"Smith TG, Gigante CM, Wynn NT, Matheny A, Davidson W, Yang Y et al (2023) Tecovirimat resistance in mpox patients, United States, 2022\u20132023. Emerg Infect Dis 29(12):2426","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"11421_CR176","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.3201\/eid2912.230849","volume":"29","author":"CA Contag","year":"2023","unstructured":"Contag CA, Mische L, Fong I, Karan A, Vaidya A, McCormick DW et al (2023) Treatment of mpox with suspected tecovirimat resistance in immunocompromised patient, United States, 2022. Emerg Infect Dis 29(12):2520","journal-title":"Emerg Infect Dis"},{"issue":"10380","key":"11421_CR177","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(23)00273-8","volume":"401","author":"O Mitj\u00e0","year":"2023","unstructured":"Mitj\u00e0 O, Alemany A, Marks M, Mora JIL, Rodr\u00edguez-Aldama JC, Silva MST et al (2023) Mpox in people with advanced HIV infection: a global case series. Lancet 401(10380):939\u2013949","journal-title":"Lancet"},{"issue":"20","key":"11421_CR178","doi-asserted-by":"publisher","first-page":"13139","DOI":"10.1128\/JVI.79.20.13139-13149.2005","volume":"79","author":"G Yang","year":"2005","unstructured":"Yang G, Pevear DC, Davies MH, Collett MS, Bailey T, Rippen S et al (2005) An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus challenge. J Virol 79(20):13139\u201313149","journal-title":"J Virol"},{"issue":"19","key":"11421_CR179","doi-asserted-by":"publisher","first-page":"9391","DOI":"10.1128\/JVI.00605-06","volume":"80","author":"G Andrei","year":"2006","unstructured":"Andrei G, Gammon DB, Fiten P, De Clercq E, Opdenakker G, Snoeck R et al (2006) Cidofovir resistance in vaccinia virus is linked to diminished virulencein mice. J Virol 80(19):9391\u20139401","journal-title":"J Virol"},{"issue":"6","key":"11421_CR180","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1177\/095632020101200602","volume":"12","author":"DF Smee","year":"2001","unstructured":"Smee DF, Bray M, Huggins JW (2001) Antiviral activity and mode of action studies of ribavirin and mycophenolic acid against orthopoxviruses in vitro. Antivir Chem Chemother 12(6):327\u2013335","journal-title":"Antivir Chem Chemother"},{"issue":"1-2","key":"11421_CR181","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0166-3542(02)00196-1","volume":"57","author":"RO Baker","year":"2003","unstructured":"Baker RO, Bray M, Huggins JW (2003) Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections. Antivir Res 57(1\u20132):13\u201323","journal-title":"Antivir Res"},{"issue":"12","key":"11421_CR182","doi-asserted-by":"publisher","first-page":"4038","DOI":"10.1128\/AAC.00380-06","volume":"50","author":"RS Kornbluth","year":"2006","unstructured":"Kornbluth RS, Smee DF, Sidwell RW, Snarsky V, Evans DH, Hostetler KY (2006) Mutations in the E9L polymerase gene of cidofovir-resistant vaccinia virus strain WR are associated with the drug resistance phenotype. Antimicrob Agents Chemother 50(12):4038\u20134043","journal-title":"Antimicrob Agents Chemother"},{"key":"11421_CR183","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.antiviral.2014.08.003","volume":"111","author":"S Parker","year":"2014","unstructured":"Parker S, Crump R, Foster S, Hartzler H, Hembrador E, Lanier ER et al (2014) Co-administration of the broad-spectrum antiviral, brincidofovir (CMX001), with smallpox vaccine does not compromise vaccine protection in mice challenged with ectromelia virus. Antivir Res 111:42\u201352","journal-title":"Antivir Res"},{"issue":"10","key":"11421_CR184","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.3390\/life13101969","volume":"13","author":"G Bruno","year":"2023","unstructured":"Bruno G, Buccoliero GB (2023) Antivirals against monkeypox (Mpox) in humans: an updated narrative review. Life 13(10):1969","journal-title":"Life"},{"issue":"2","key":"11421_CR185","doi-asserted-by":"publisher","first-page":"A84","DOI":"10.1016\/j.antiviral.2009.01.005","volume":"82","author":"KY Hostetler","year":"2009","unstructured":"Hostetler KY (2009) Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: current state of the art. Antiviral Res 82(2):A84\u2013A98","journal-title":"Antiviral Res"},{"key":"11421_CR186","doi-asserted-by":"publisher","first-page":"132231","DOI":"10.1016\/j.ijbiomac.2024.132231","volume":"270","author":"Y Xu","year":"2024","unstructured":"Xu Y, Wu Y, Wu X, Zhang Y, Yang Y, Li D et al (2024) Structural basis of human mpox viral DNA replication inhibition by brincidofovir and cidofovir. Int J Biol Macromol 270:132231","journal-title":"Int J Biol Macromol"},{"issue":"5","key":"11421_CR187","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/jac\/dku545","volume":"70","author":"S Duraffour","year":"2015","unstructured":"Duraffour S, Lorenzo MM, Z\u00f6ller G, Topalis D, Grosenbach D, Hruby DE et al (2015) ST-246 is a key antiviral to inhibit the viral F13L phospholipase, one of the essential proteins for orthopoxvirus wrapping. J Antimicrob Chemother 70(5):1367\u20131380","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"11421_CR188","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1099\/jgv.0.000422","volume":"97","author":"OY Mazurkov","year":"2016","unstructured":"Mazurkov OY, Kabanov AS, Shishkina LN, Sergeev AA, Skarnovich MO, Bormotov NI et al (2016) New effective chemically synthesized anti-smallpox compound NIOCH-14. J Gen Virol 97(5):1229\u20131239","journal-title":"J Gen Virol"},{"issue":"3","key":"11421_CR189","doi-asserted-by":"publisher","first-page":"e28652","DOI":"10.1002\/jmv.28652","volume":"95","author":"D Bojkova","year":"2023","unstructured":"Bojkova D, Z\u00f6ller N, Tietgen M, Steinhorst K, Bechtel M, Rothenburger T et al (2023) Repurposing of the antibiotic nitroxoline for the treatment of mpox. J Med Virol 95(3):e28652","journal-title":"J Med Virol"},{"issue":"4","key":"11421_CR190","doi-asserted-by":"publisher","first-page":"e00566-23","DOI":"10.1128\/spectrum.00566-23","volume":"11","author":"T Hishiki","year":"2023","unstructured":"Hishiki T, Morita T, Akazawa D, Ohashi H, Park E-S, Kataoka M et al (2023) Identification of IMP dehydrogenase as a potential target for anti-mpox virus agents. Microbiol Spectr 11(4):e00566-23","journal-title":"Microbiol Spectr"},{"key":"11421_CR191","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7132e4","author":"J O\u2019Shea","year":"2022","unstructured":"O\u2019Shea J (2022) Interim guidance for prevention and treatment of monkeypox in persons with HIV infection\u2014United States, August 2022. MMWR Morb Mortal Wkly Rep. https:\/\/doi.org\/10.15585\/mmwr.mm7132e4","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"11421_CR192","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7137e1","author":"K O\u2019Laughlin","year":"2022","unstructured":"O\u2019Laughlin K (2022) Clinical use of tecovirimat (Tpoxx) for treatment of monkeypox under an investigational new drug protocol\u2014United States, May\u2013August 2022. MMWR Morb Mortal Wkly Rep. https:\/\/doi.org\/10.15585\/mmwr.mm7137e1","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6619","key":"11421_CR193","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1126\/science.add4153","volume":"378","author":"CM Gigante","year":"2022","unstructured":"Gigante CM, Korber B, Seabolt MH, Wilkins K, Davidson W, Rao AK et al (2022) Multiple lineages of monkeypox virus detected in the United States, 2021\u20132022. Science 378(6619):560\u2013565","journal-title":"Science"},{"issue":"2","key":"11421_CR194","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1128\/AAC.48.2.404-412.2004","volume":"48","author":"DC Quenelle","year":"2004","unstructured":"Quenelle DC, Collins DJ, Wan WB, Beadle JR, Hostetler KY, Kern ER (2004) Oral treatment of cowpox and vaccinia virus infections in mice with ether lipid esters of cidofovir. Antimicrob Agents Chemother 48(2):404\u2013412","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"11421_CR195","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/14787210.2020.1819791","volume":"19","author":"AT Russo","year":"2021","unstructured":"Russo AT, Grosenbach DW, Chinsangaram J, Honeychurch KM, Long PG, Lovejoy C et al (2021) An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications. Expert Rev Anti-Infect Ther 19(3):331\u2013344","journal-title":"Expert Rev Anti-Infect Ther"},{"issue":"2","key":"11421_CR196","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3390\/v14020388","volume":"14","author":"IV Babkin","year":"2022","unstructured":"Babkin IV, Babkina IN, Tikunova NV (2022) An update of orthopoxvirus molecular evolution. Viruses 14(2):388","journal-title":"Viruses"},{"key":"11421_CR197","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-025-01936-6","author":"R Vernuccio","year":"2025","unstructured":"Vernuccio R, Mart\u00ednez Le\u00f3n A, Poojari CS, Buchrieser J, Selverian CN, Jaleta Y et al (2025) Structural insights into tecovirimat antiviral activity and poxvirus resistance. Nat Microbiol. https:\/\/doi.org\/10.1038\/s41564-025-01936-6","journal-title":"Nat Microbiol"},{"issue":"11","key":"11421_CR198","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.1128\/AAC.00762-07","volume":"51","author":"DC Quenelle","year":"2007","unstructured":"Quenelle DC, Prichard MN, Keith KA, Hruby DE, Jordan R, Painter GR et al (2007) Synergistic efficacy of the combination of ST-246 with CMX001 against orthopoxviruses. Antimicrob Agents Chemother 51(11):4118\u20134124","journal-title":"Antimicrob Agents Chemother"},{"issue":"24","key":"11421_CR199","doi-asserted-by":"publisher","first-page":"12520","DOI":"10.1128\/JVI.01528-08","volume":"82","author":"DB Gammon","year":"2008","unstructured":"Gammon DB, Snoeck R, Fiten P, Krecmerov\u00e1 M, Hol\u00fd A, De Clercq E et al (2008) Mechanism of antiviral drug resistance of vaccinia virus: identification of residues in the viral DNA polymerase conferring differential resistance to antipoxvirus drugs. J Virol 82(24):12520\u201312534","journal-title":"J Virol"},{"issue":"8","key":"11421_CR200","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1128\/AAC.49.8.3153-3162.2005","volume":"49","author":"WC Magee","year":"2005","unstructured":"Magee WC, Hostetler KY, Evans DH (2005) Mechanism of inhibition of vaccinia virus DNA polymerase by cidofovir diphosphate. Antimicrob Agents Chemother 49(8):3153\u20133162","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"11421_CR201","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.3390\/v2122803","volume":"2","author":"G Andrei","year":"2010","unstructured":"Andrei G, Snoeck R (2010) Cidofovir activity against poxvirus infections. Viruses 2(12):2803","journal-title":"Viruses"},{"issue":"2","key":"11421_CR202","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/ajhp\/zxac300","volume":"80","author":"M Aldhaeefi","year":"2023","unstructured":"Aldhaeefi M, Rungkitwattanakul D, Unonu J, Franklin C-J, Lyons J, Hager K et al (2023) The 2022 human monkeypox outbreak: clinical review and management guidance. Am J Health-Syst Pharm 80(2):44\u201352","journal-title":"Am J Health-Syst Pharm"},{"key":"11421_CR203","doi-asserted-by":"crossref","unstructured":"Chiem K, Nogales A, Lorenzo M, Vasquez DM, Xiang Y, Gupta YK, et al. Antivirals against monkeypox infections. bioRxiv. 2023:2023.04.-19.537483","DOI":"10.1101\/2023.04.19.537483"},{"issue":"1","key":"11421_CR204","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/cid\/ciac622","volume":"76","author":"EA Siegrist","year":"2023","unstructured":"Siegrist EA, Sassine J (2023) Antivirals with activity against Mpox: a clinically oriented review. Clin Infect Dis 76(1):155\u2013164","journal-title":"Clin Infect Dis"},{"issue":"12","key":"11421_CR205","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.3201\/eid2912.231146","volume":"29","author":"TG Smith","year":"2023","unstructured":"Smith TG, Gigante CM, Wynn NT, Matheny A, Davidson W, Yang Y et al (2023) Tecovirimat resistance in Mpox patients, United States, 2022-2023. Emerg Infect Dis 29(12):2426\u20132432","journal-title":"Emerg Infect Dis"},{"key":"11421_CR206","doi-asserted-by":"crossref","unstructured":"Hurst JR, Addo M, Li A, Khera SS, Persaud R, Bertucci C, et al. (2025). Monkeypox virus shedding despite tecovirimat treatment in a cohort in Toronto, Canada. J Infect Dis","DOI":"10.1093\/infdis\/jiaf471"},{"issue":"40","key":"11421_CR207","doi-asserted-by":"publisher","first-page":"903","DOI":"10.15585\/mmwr.mm7340a3","volume":"73","author":"CM Gigante","year":"2024","unstructured":"Gigante CM, Takakuwa J, McGrath D, Kling C, Smith TG, Peng M et al (2024) Notes from the field: Mpox cluster caused by Tecovirimat-resistant monkeypox virus\u2014five states, October 2023-February 2024. MMWR Morb Mortal Wkly Rep 73(40):903\u2013905","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8","key":"11421_CR208","first-page":"e67872","volume":"16","author":"S Mani","year":"2024","unstructured":"Mani S, Ganesan A, Arunagiri T, Ravi Kumaran V, Kannaiah KP, Vellapandian C et al (2024) Epidemiology, virology, and mutation landscape of monkeypox virus from past to present. Cureus 16(8):e67872","journal-title":"Cureus"},{"issue":"7","key":"11421_CR209","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.3390\/biomedicines12071457","volume":"12","author":"MA Zinnah","year":"2024","unstructured":"Zinnah MA, Uddin MB, Hasan T, Das S, Khatun F, Hasan MH et al (2024) The re-emergence of Mpox: old illness, modern challenges. Biomedicines 12(7):1457","journal-title":"Biomedicines"},{"key":"11421_CR210","doi-asserted-by":"publisher","first-page":"102928","DOI":"10.1016\/j.jaut.2022.102928","volume":"133","author":"SR Kannan","year":"2022","unstructured":"Kannan SR, Sachdev S, Reddy AS, Kandasamy SL, Byrareddy SN, Lorson CL et al (2022) Mutations in the monkeypox virus replication complex: potential contributing factors to the 2022 outbreak. J Autoimmun 133:102928","journal-title":"J Autoimmun"},{"issue":"6","key":"11421_CR211","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41579-018-0003-6","volume":"16","author":"Y Choi","year":"2018","unstructured":"Choi Y, Bowman JW, Jung JU (2018) Autophagy during viral infection\u2014a double-edged sword. Nat Rev Microbiol 16(6):341\u2013354","journal-title":"Nat Rev Microbiol"},{"issue":"9","key":"11421_CR212","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3390\/v11090776","volume":"11","author":"H-c Yin","year":"2019","unstructured":"Yin H-c, Shao S-l, Jiang X-j, Xie P-y, Sun W-s, Yu T-f (2019) Interactions between autophagy and DNA viruses. Viruses 11(9):776","journal-title":"Viruses"},{"key":"11421_CR213","doi-asserted-by":"publisher","first-page":"1662511","DOI":"10.3389\/fcimb.2025.1662511","volume":"15","author":"Y Li","year":"2025","unstructured":"Li Y, Miao X, Jia R, Liu R (2025) Emerging interplays between poxviruses and autophagy. Front Cell Infect Microbiol 15:1662511","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"11421_CR214","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1089\/vim.2013.0003","volume":"26","author":"L Martyniszyn","year":"2013","unstructured":"Martyniszyn L, Szulc-D\u0105browska L, Boraty\u0144ska-Jasi\u0144ska A, Struzik J, Winnicka A, Niemia\u0142towski M (2013) Crosstalk between autophagy and apoptosis in RAW 264.7 macrophages infected with ectromelia orthopoxvirus. Viral Immunol 26(5):322\u2013335","journal-title":"Viral Immunol"},{"issue":"1-2","key":"11421_CR215","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1615\/ForumImmunDisTher.2015014188","volume":"6","author":"J Lee","year":"2015","unstructured":"Lee J, Ahn E, Kissick HT, Ahmed R (2015) Reinvigorating exhausted T cells by blockade of the PD-1 pathway. Front Immunopathol Dis Ther 6(1\u20132):7\u201317","journal-title":"Front Immunopathol Dis Ther"},{"issue":"4","key":"11421_CR216","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1084\/jem.20121416","volume":"210","author":"BH Zinselmeyer","year":"2013","unstructured":"Zinselmeyer BH, Heydari S, Sacrist\u00e1n C, Nayak D, Cammer M, Herz J et al (2013) PD-1 promotes immune exhaustion by inducing antiviral T cell motility paralysis. J Exp Med 210(4):757\u2013774","journal-title":"J Exp Med"},{"key":"11421_CR217","doi-asserted-by":"publisher","first-page":"869768","DOI":"10.3389\/fimmu.2022.869768","volume":"13","author":"KM Viramontes","year":"2022","unstructured":"Viramontes KM, Neubert EN, DeRogatis JM, Tinoco R (2022) PD-1 immune checkpoint blockade and PSGL-1 inhibition synergize to reinvigorate exhausted T cells. Front Immunol 13:869768","journal-title":"Front Immunol"},{"issue":"2","key":"11421_CR218","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1158\/2326-6066.CIR-21-0515","volume":"10","author":"N Budimir","year":"2022","unstructured":"Budimir N, Thomas GD, Dolina JS, Salek-Ardakani S (2022) Reversing T-cell exhaustion in cancer: lessons learned from PD-1\/PD-L1 immune checkpoint blockade. Cancer Immunol Res 10(2):146\u2013153","journal-title":"Cancer Immunol Res"},{"key":"11421_CR219","doi-asserted-by":"publisher","first-page":"154535","DOI":"10.1016\/j.prp.2023.154535","volume":"247","author":"R Wu","year":"2023","unstructured":"Wu R, Tong S, Yin J, Zhu Z, Mao Z, Xu L (2023) Oncolytic vaccinia virus acts synergistically with anti-PD-L1 antibody to enhance the killing of colon cancer cells by CD8+ T cells. Pathol Res Pract 247:154535","journal-title":"Pathol Res Pract"},{"issue":"1","key":"11421_CR220","doi-asserted-by":"publisher","first-page":"14754","DOI":"10.1038\/ncomms14754","volume":"8","author":"Z Liu","year":"2017","unstructured":"Liu Z, Ravindranathan R, Kalinski P, Guo ZS, Bartlett DL (2017) Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy. Nat Commun 8(1):14754","journal-title":"Nat Commun"},{"issue":"3","key":"11421_CR221","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1084\/jem.20071949","volume":"205","author":"S-J Ha","year":"2008","unstructured":"Ha S-J, Mueller SN, Wherry EJ, Barber DL, Aubert RD, Sharpe AH et al (2008) Enhancing therapeutic vaccination by blocking PD-1\u2013mediated inhibitory signals during chronic infection. J Exp Med 205(3):543\u2013555","journal-title":"J Exp Med"},{"key":"11421_CR222","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-011145","author":"JE Moseman","year":"2025","unstructured":"Moseman JE, Rastogi I, Jeon D, McNeel DG (2025) PD-1 blockade employed at the time CD8+ T cells are activated enhances their antitumor efficacy. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2024-011145","journal-title":"J Immunother Cancer"},{"key":"11421_CR223","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.142513","author":"CC Balan\u00e7a","year":"2021","unstructured":"Balan\u00e7a CC, Salvioni A, Scarlata CM, Michelas M, Martinez-Gomez C, Gomez-Roca C et al (2021) PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1hiCD39+ CD4 T cells. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.142513","journal-title":"JCI Insight"},{"issue":"4","key":"11421_CR224","doi-asserted-by":"publisher","first-page":"e2194","DOI":"10.1002\/rmv.2194","volume":"31","author":"LN Al-Eitan","year":"2021","unstructured":"Al-Eitan LN, Alahmad SZ (2021) Pharmacogenomics of genetic polymorphism within the genes responsible for SARS-CoV-2 susceptibility and the drug-metabolising genes used in treatment. Rev Med Virol 31(4):e2194","journal-title":"Rev Med Virol"},{"issue":"4","key":"11421_CR225","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/sj.tpj.6500374","volume":"6","author":"S Rodr\u00edguez-N\u00f3voa","year":"2006","unstructured":"Rodr\u00edguez-N\u00f3voa S, Barreiro P, Jim\u00e9nez-N\u00e1cher I, Soriano V (2006) Overview of the pharmacogenetics of HIV therapy. Pharmacogenom J 6(4):234\u2013245","journal-title":"Pharmacogenom J"},{"issue":"9","key":"11421_CR226","doi-asserted-by":"publisher","first-page":"4088","DOI":"10.1002\/jmv.27849","volume":"94","author":"MK Vakil","year":"2022","unstructured":"Vakil MK, Mansoori Y, Al-Awsi GRL, Hosseinipour A, Ahsant S, Ahmadi S et al (2022) Individual genetic variability mainly of proinflammatory cytokines, cytokine receptors, and toll-like receptors dictates pathophysiology of COVID-19 disease. J Med Virol 94(9):4088\u20134096","journal-title":"J Med Virol"},{"issue":"1","key":"11421_CR227","doi-asserted-by":"publisher","first-page":"100669","DOI":"10.1016\/j.trre.2021.100669","volume":"36","author":"N Redondo","year":"2022","unstructured":"Redondo N, Navarro D, Aguado JM, Fern\u00e1ndez-Ruiz M (2022) Human genetic polymorphisms and risk of viral infection after solid organ transplantation. Transplant Rev Orlando 36(1):100669","journal-title":"Transplant Rev Orlando"},{"issue":"1","key":"11421_CR228","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13073-018-0568-8","volume":"10","author":"P Scepanovic","year":"2018","unstructured":"Scepanovic P, Alanio C, Hammer C, Hodel F, Bergstedt J, Patin E et al (2018) Human genetic variants and age are the strongest predictors of humoral immune responses to common pathogens and vaccines. Genome Med 10(1):59","journal-title":"Genome Med"},{"key":"11421_CR229","doi-asserted-by":"publisher","first-page":"1540253","DOI":"10.3389\/fimmu.2025.1540253","volume":"16","author":"S Kumar Mishra","year":"2025","unstructured":"Kumar Mishra S, Kumar N, Or Rashid MH, Sultana S, Dawoud TM, Bourhia M, Georrge JJ (2025) An integrated mutation-based immunoinformatic approach incorporating variability in epitopes: a study based on HIV subtype C. Front Immunol 16:1540253","journal-title":"Front Immunol"},{"issue":"9","key":"11421_CR230","doi-asserted-by":"publisher","first-page":"a010199","DOI":"10.1101\/cshperspect.a010199","volume":"5","author":"B Moss","year":"2013","unstructured":"Moss B (2013) Poxvirus DNA replication. Cold Spring Harb Perspect Biol 5(9):a010199","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"3","key":"11421_CR231","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ijid.2005.12.001","volume":"10","author":"R Wittek","year":"2006","unstructured":"Wittek R (2006) Vaccinia immune globulin: current policies, preparedness, and product safety and efficacy. Int J Infect Dis 10(3):193\u2013201","journal-title":"Int J Infect Dis"},{"key":"11421_CR232","doi-asserted-by":"publisher","first-page":"D54","DOI":"10.1016\/j.vaccine.2011.04.014","volume":"29","author":"IK Damon","year":"2011","unstructured":"Damon IK (2011) Status of human monkeypox: clinical disease, epidemiology and research. Vaccine 29:D54\u2013D59","journal-title":"Vaccine"},{"issue":"5","key":"11421_CR233","doi-asserted-by":"publisher","first-page":"e28791","DOI":"10.1002\/jmv.28791","volume":"95","author":"M Rueca","year":"2023","unstructured":"Rueca M, Tucci FG, Mazzotta V, Gramigna G, Gruber CEM, Fabeni L et al (2023) Temporal intra\u2010host variability of mpox virus genomes in multiple body tissues. J Med Virol 95(5):e28791","journal-title":"J Med Virol"},{"issue":"1","key":"11421_CR234","doi-asserted-by":"publisher","first-page":"e01526-22","DOI":"10.1128\/mbio.01526-22","volume":"14","author":"G Brennan","year":"2023","unstructured":"Brennan G, Stoian AMM, Yu H, Rahman MJ, Banerjee S, Stroup JN et al (2023) Molecular mechanisms of poxvirus evolution. MBio 14(1):e01526-22","journal-title":"MBio"},{"issue":"2","key":"11421_CR235","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1016\/S1473-3099(23)00482-6","volume":"24","author":"C Pinnetti","year":"2024","unstructured":"Pinnetti C, Cimini E, Mazzotta V, Matusali G, Vergori A, Mondi A et al (2024) Mpox as AIDS-defining event with a severe and protracted course: clinical, immunological, and virological implications. Lancet Infect Dis 24(2):e127\u2013e135","journal-title":"Lancet Infect Dis"},{"key":"11421_CR236","unstructured":"Gammon DB (2010) Vaccinia virus DNA polymerase and ribonucleotide reductase: their role in replication, recombination and drug resistance"},{"issue":"3","key":"11421_CR237","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3390\/biomedicines10030580","volume":"10","author":"G Andrei","year":"2022","unstructured":"Andrei G, Fiten P, Kre\u010dmerov\u00e1 M, Opdenakker G, Topalis D, Snoeck R (2022) Poxviruses bearing DNA polymerase mutations show complex patterns of cross-resistance. Biomedicines 10(3):580","journal-title":"Biomedicines"},{"issue":"4","key":"11421_CR238","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1134\/S0022476624040139","volume":"65","author":"SS Borisevich","year":"2024","unstructured":"Borisevich SS, Gorokhov YV, Arkhipov SG (2024) Binding site of Tecovirimat, inhibitor of the p37 membrane protein of Orthopox viruses. J Struct Chem 65(4):776\u2013785","journal-title":"J Struct Chem"},{"issue":"Supplement_2","key":"11421_CR239","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1093\/infdis\/jiad465","volume":"229","author":"JT Brooks","year":"2024","unstructured":"Brooks JT, Reynolds MG, Torrone E, McCollum A, Spicknall IH, Gigante CM et al (2024) How the orthodox features of orthopoxviruses led to an unorthodox Mpox outbreak: what we\u2019ve learned, and what we still need to understand. J Infect Dis 229(Supplement_2):S121\u2013S131","journal-title":"J Infect Dis"},{"issue":"1","key":"11421_CR240","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/s41591-024-03370-3","volume":"31","author":"JR Otieno","year":"2025","unstructured":"Otieno JR, Ruis C, Onoja AB, Kuppalli K, Hoxha A, Nitsche A et al (2025) Global genomic surveillance of monkeypox virus. Nat Med 31(1):342\u2013350","journal-title":"Nat Med"},{"key":"11421_CR241","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7340a3","author":"CM Gigante","year":"2024","unstructured":"Gigante CM (2024) Notes from the field: Mpox cluster caused by tecovirimat-resistant monkeypox virus\u2014five states, october 2023\u2013february 2024. MMWR Morb Mortal Wkly Rep. https:\/\/doi.org\/10.15585\/mmwr.mm7340a3","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"11421_CR242","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.3390\/ijerph20042963","volume":"20","author":"SM Malone","year":"2023","unstructured":"Malone SM, Mitra AK, Onumah NA, Brown A, Jones LM, Tresvant DC et al (2023) Safety and efficacy of post-eradication smallpox vaccine as an mpox vaccine: a systematic review with meta-analysis. Int J Environ Res Public Health 20(4):2963","journal-title":"Int J Environ Res Public Health"},{"issue":"7","key":"11421_CR243","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2183\/pjab.93.027","volume":"93","author":"Y Furuta","year":"2017","unstructured":"Furuta Y, Komeno T, Nakamura T (2017) Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase. Proc Jpn Acad Ser B Phys Biol Sci 93(7):449\u2013463","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"issue":"12","key":"11421_CR244","doi-asserted-by":"publisher","first-page":"e01226-22","DOI":"10.1128\/aac.01226-22","volume":"66","author":"CE DeLaurentis","year":"2022","unstructured":"DeLaurentis CE, Kiser J, Zucker J (2022) New perspectives on antimicrobial agents: tecovirimat for treatment of human monkeypox virus. Antimicrob Agents Chemother 66(12):e01226-22","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"11421_CR245","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.3390\/v2122740","volume":"2","author":"R Lanier","year":"2010","unstructured":"Lanier R, Trost L, Tippin T, Lampert B, Robertson A, Foster S et al (2010) Development of CMX001 for the treatment of poxvirus infections. Viruses 2(12):2740","journal-title":"Viruses"},{"issue":"13","key":"11421_CR246","doi-asserted-by":"publisher","first-page":"7310","DOI":"10.1128\/JVI.00355-12","volume":"86","author":"S Duraffour","year":"2012","unstructured":"Duraffour S, Andrei G, Topalis D, Kre\u010dmerov\u00e1 M, Crance J-M, Garin D et al (2012) Mutations conferring resistance to viral DNA polymerase inhibitors in camelpox virus give different drug-susceptibility profiles in vaccinia virus. J Virol 86(13):7310\u20137325","journal-title":"J Virol"},{"issue":"1","key":"11421_CR247","doi-asserted-by":"publisher","first-page":"e28229","DOI":"10.1002\/jmv.28229","volume":"95","author":"E Khani","year":"2023","unstructured":"Khani E, Afsharirad B, Entezari-Maleki T (2023) Monkeypox treatment: current evidence and future perspectives. J Med Virol 95(1):e28229","journal-title":"J Med Virol"},{"key":"11421_CR248","unstructured":"ADMINISTRATION USFD. 12\/19\/2024 [Available from: https:\/\/www.fda.gov\/emergency-preparedness-and-response\/mcm-issues\/mpox#therapeutics"},{"issue":"7","key":"11421_CR249","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1056\/NEJMp2210125","volume":"387","author":"A Sherwat","year":"2022","unstructured":"Sherwat A, Brooks JT, Birnkrant D, Kim P (2022) Tecovirimat and the treatment of monkeypox\u2014past, present, and future considerations. N Engl J Med 387(7):579\u2013581","journal-title":"N Engl J Med"},{"issue":"3","key":"11421_CR250","first-page":"181","volume":"13","author":"S Duraffour","year":"2010","unstructured":"Duraffour S, Andrei G, Snoeck R (2010) Tecovirimat, a p37 envelope protein inhibitor for the treatment of smallpox infection. IDrugs 13(3):181\u2013191","journal-title":"IDrugs"},{"key":"11421_CR251","unstructured":"PubChem [Internet]. Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information; 2004-. PubChem Compound Summary for CID 16124688, Tecovirimat; [cited 2025 Apr. 2]. Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Tecovirimat"},{"key":"11421_CR252","doi-asserted-by":"publisher","first-page":"e230056","DOI":"10.1590\/0074-02760230056","volume":"118","author":"DDS Nunes","year":"2023","unstructured":"Nunes DDS, Higa LM, Oliveira RL, da Costa LC, Bomfim LM, Gon\u00e7alves CCA et al (2023) In vitro susceptibility of eighteen clinical isolates of human monkeypox virus to tecovirimat. Mem Inst Oswaldo Cruz 118:e230056","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"12","key":"11421_CR253","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1038\/s41564-022-01269-8","volume":"7","author":"G Frenois-Veyrat","year":"2022","unstructured":"Frenois-Veyrat G, Gallardo F, Gorg\u00e9 O, Marcheteau E, Ferraris O, Baidaliuk A et al (2022) Tecovirimat is effective against human monkeypox virus in vitro at nanomolar concentrations. Nat Microbiol 7(12):1951\u20131955","journal-title":"Nat Microbiol"},{"issue":"673","key":"11421_CR254","doi-asserted-by":"publisher","first-page":"eade7646","DOI":"10.1126\/scitranslmed.ade7646","volume":"14","author":"BM Warner","year":"2022","unstructured":"Warner BM, Klassen L, Sloan A, Deschambault Y, Soule G, Banadyga L et al (2022) In vitro and in vivo efficacy of tecovirimat against a recently emerged 2022 monkeypox virus isolate. Sci Transl Med 14(673):eade7646","journal-title":"Sci Transl Med"},{"key":"11421_CR255","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015769\/full","author":"T Fox","year":"2023","unstructured":"Fox T, Gould S, Princy N, Rowland T, Lutje V, Kuehn R (2023) Therapeutics for treating mpox in humans. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD015769\/full","journal-title":"Cochrane Database Syst Rev"},{"issue":"37","key":"11421_CR256","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.15585\/mmwr.mm7137e1","volume":"71","author":"K O'Laughlin","year":"2022","unstructured":"O\u2019Laughlin K, Tobolowsky FA, Elmor R, Overton R, O\u2019Connor SM, Damon IK et al (2022) Clinical use of tecovirimat (Tpoxx) for treatment of monkeypox under an investigational new drug protocol\u2014United States, May-August 2022. MMWR Morb Mortal Wkly Rep 71(37):1190\u20131195","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"11421_CR257","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.jiac.2023.11.025","volume":"30","author":"Y Akiyama","year":"2024","unstructured":"Akiyama Y, Morioka S, Tsuzuki S, Yoshikawa T, Yamato M, Nakamura H et al (2024) Efficacy and viral dynamics of tecovirimat in patients with MPOX: a multicenter open-label, double-arm trial in Japan. J Infect Chemother 30(6):488\u2013493","journal-title":"J Infect Chemother"},{"key":"11421_CR258","unstructured":"PubChem [Internet]. Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information; 2004-. PubChem Compound Summary for CID 483477, Brincidofovir; [cited 2025 Apr. 2]. Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Brincidofovir"},{"key":"11421_CR259","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00927-20","author":"CL Hutson","year":"2021","unstructured":"Hutson CL, Kondas AV, Mauldin MR, Doty JB, Grossi IM, Morgan CN et al (2021) Pharmacokinetics and efficacy of a potential smallpox therapeutic, brincidofovir, in a lethal monkeypox virus animal model. mSphere. https:\/\/doi.org\/10.1128\/mSphere.00927-20","journal-title":"mSphere"},{"issue":"6","key":"11421_CR260","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1128\/AAC.00238-15","volume":"59","author":"GD Tylden","year":"2015","unstructured":"Tylden GD, Hirsch HH, Rinaldo CH (2015) Brincidofovir (CMX001) inhibits BK polyomavirus replication in primary human urothelial cells. Antimicrob Agents Chemother 59(6):3306\u20133316","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"11421_CR261","doi-asserted-by":"publisher","first-page":"2220572","DOI":"10.1080\/22221751.2023.2220572","volume":"12","author":"S Guo","year":"2023","unstructured":"Guo S, Zhang Y, Liu Z, Wang D, Liu H, Li L et al (2023) Brincidofovir is a robust replication inhibitor against African swine fever virus in vivo and in vitro. Emerg Microbes Infect 12(2):2220572","journal-title":"Emerg Microbes Infect"},{"key":"11421_CR262","doi-asserted-by":"publisher","first-page":"107015","DOI":"10.1016\/j.ijid.2024.107015","volume":"143","author":"RM Alameer","year":"2024","unstructured":"Alameer RM, Yamani A, Al-Saud A, Alsobayeg S, Alamro B, Alali A et al (2024) The successful treatment of mpox with brincidofovir in renal transplant recipients-a report of 2 cases. Int J Infect Dis 143:107015","journal-title":"Int J Infect Dis"},{"key":"11421_CR263","unstructured":"https:\/\/www.fda.gov\/drugs\/investigational-new-drug-ind-application\/emergency-investigational-new-drug-eind-applications-antiviral-products"},{"key":"11421_CR264","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ijid.2022.11.040","volume":"127","author":"MA Shamim","year":"2023","unstructured":"Shamim MA, Padhi BK, Satapathy P, Veeramachaneni SD, Chatterjee C, Tripathy S et al (2023) The use of antivirals in the treatment of human monkeypox outbreaks: a systematic review. Int J Infect Dis 127:150\u2013161","journal-title":"Int J Infect Dis"},{"key":"11421_CR265","unstructured":"Tecovirimat. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012"},{"issue":"6087","key":"11421_CR266","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/323464a0","volume":"323","author":"ED Clercq","year":"1986","unstructured":"Clercq ED, Hol\u00fd A, Rosenberg I, Sakuma T, Balzarini J, Maudgal PC (1986) A novel selective broad-spectrum anti-DNA virus agent. Nature 323(6087):464\u2013467","journal-title":"Nature"},{"issue":"8","key":"11421_CR267","first-page":"30","volume":"2","author":"Food and Drug Administration","year":"1996","unstructured":"Food and Drug Administration (1996) FDA approves cidofovir for treatment of CMV retinitis. J Int assoc physicians aIDs Care 2(8):30","journal-title":"J Int assoc physicians aIDs Care"},{"key":"11421_CR268","unstructured":"Medicine NLo. [Available from: https:\/\/www.dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=90639fc6-0295-4115-98f0-054b783850ce"},{"issue":"1","key":"11421_CR269","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jinf.2022.11.001","volume":"86","author":"A Mondi","year":"2023","unstructured":"Mondi A, Gagliardini R, Mazzotta V, Vita S, Carletti F, Pinnetti C et al (2023) Clinical experience with use of oral Tecovirimat or intravenous Cidofovir for the treatment of Monkeypox in an Italian reference hospital. J Infect 86(1):66\u2013117","journal-title":"J Infect"},{"issue":"1","key":"11421_CR270","doi-asserted-by":"publisher","first-page":"e28218","DOI":"10.1002\/jmv.28218","volume":"95","author":"AR Raccagni","year":"2023","unstructured":"Raccagni AR, Candela C, Bruzzesi E, Mileto D, Canetti D, Rizzo A et al (2023) Real-life use of cidofovir for the treatment of severe monkeypox cases. J Med Virol 95(1):e28218","journal-title":"J Med Virol"},{"key":"11421_CR271","unstructured":"Administration. UFaD. Vistide [Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/1999\/020638s003lbl.pdf"},{"issue":"9","key":"11421_CR272","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1093\/cid\/ciac971","volume":"76","author":"AK Thet","year":"2023","unstructured":"Thet AK, Kelly PJ, Kasule SN, Shah AK, Chawala A, Latif A et al (2023) The use of vaccinia immune globulin in the treatment of severe mpox. Virus infection in human immunodeficiency virus\/AIDS. Clin Infect Dis 76(9):1671\u20131673","journal-title":"Clin Infect Dis"},{"issue":"9","key":"11421_CR273","doi-asserted-by":"publisher","first-page":"232","DOI":"10.15585\/mmwr.mm7209a4","volume":"72","author":"AK Rao","year":"2023","unstructured":"Rao AK, Schrodt CA, Minhaj FS, Waltenburg MA, Cash-Goldwasser S, Yu Y et al (2023) Interim clinical treatment considerations for severe manifestations of Mpox\u2014United States, February 2023. MMWR Morb Mortal Wkly Rep 72(9):232\u2013243","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"11421_CR274","doi-asserted-by":"publisher","first-page":"e28917","DOI":"10.1002\/jmv.28917","volume":"95","author":"AU Mahtani","year":"2023","unstructured":"Mahtani AU, Seelam H, Padda I, Mahmoud M, J DC, Khalil BW, et al (2023) Severe soft tissue infection: a complication of mpox in an individual with HIV coinfection requiring vaccinia intravenous immunoglobulin and intravenous tecovirimat. J Med Virol 95(7):e28917","journal-title":"J Med Virol"},{"key":"11421_CR275","unstructured":"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=a4f9f620-e6e4-4a03-a9a7-79007c8c2cfe"},{"issue":"1","key":"11421_CR276","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40265-024-02117-1","volume":"85","author":"Y Rizk","year":"2025","unstructured":"Rizk Y, Lippi G, Henry BM, Notarte KI, Rizk JG (2025) Update on Mpox management: epidemiology, vaccines and therapeutics, and regulatory changes. Drugs 85(1):1\u20139","journal-title":"Drugs"},{"issue":"4","key":"11421_CR277","doi-asserted-by":"publisher","first-page":"e0474522","DOI":"10.1128\/spectrum.04745-22","volume":"11","author":"K Chiem","year":"2023","unstructured":"Chiem K, Nogales A, Lorenzo M, Morales Vasquez D, Xiang Y, Gupta YK et al (2023) Identification of in vitro inhibitors of monkeypox replication. Microbiol Spectr 11(4):e0474522","journal-title":"Microbiol Spectr"},{"issue":"10","key":"11421_CR278","doi-asserted-by":"publisher","first-page":"6352","DOI":"10.1128\/jvi.69.10.6352-6358.1995","volume":"69","author":"EM Kane","year":"1995","unstructured":"Kane EM, Shuman S (1995) Adenosine N1-oxide inhibits vaccinia virus replication by blocking translation of viral early mRNAs. J Virol 69(10):6352\u20136358","journal-title":"J Virol"},{"issue":"3","key":"11421_CR279","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/fcp.12980","volume":"38","author":"R Dhapola","year":"2024","unstructured":"Dhapola R, Kumari S, Sharma P, KumarKushawaha P, HariKrishnaReddy D (2024) Update on monkeypox virus infection: focusing current treatment and prevention approaches. Fundam Clin Pharmacol 38(3):465\u2013478","journal-title":"Fundam Clin Pharmacol"},{"key":"11421_CR280","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01683-19","author":"D Delaune","year":"2020","unstructured":"Delaune D, Iseni F (2020) Drug development against smallpox: present and future. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.01683-19","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"11421_CR281","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s41182-024-00678-1","volume":"53","author":"A Akingbola","year":"2025","unstructured":"Akingbola A, Adegbesan CA, Adewole O, Idahor C, Odukoya T, Nwaeze E et al (2025) Understanding the resurgence of mpox: key drivers and lessons from recent outbreaks in Africa. Trop Med Health 53(1):47","journal-title":"Trop Med Health"},{"key":"11421_CR282","doi-asserted-by":"publisher","first-page":"106797","DOI":"10.1016\/j.compbiomed.2023.106797","volume":"158","author":"A Khan","year":"2023","unstructured":"Khan A, Adil S, Qudsia HA, Waheed Y, Alshabrmi FM, Wei D-Q (2023) Structure-based design of promising natural products to inhibit thymidylate kinase from Monkeypox virus and validation using free energy calculations. Comput Biol Med 158:106797","journal-title":"Comput Biol Med"},{"key":"11421_CR283","doi-asserted-by":"publisher","first-page":"107130","DOI":"10.1016\/j.ijid.2024.107130","volume":"146","author":"D Goletti","year":"2024","unstructured":"Goletti D, Ong CWM, Friedland JS (2024) Host-directed therapies: old and new approaches for the treatment of infections. Int J Infect Dis 146:107130","journal-title":"Int J Infect Dis"},{"key":"11421_CR284","doi-asserted-by":"publisher","first-page":"100058","DOI":"10.1016\/j.crphar.2021.100058","volume":"2","author":"D Tripathi","year":"2021","unstructured":"Tripathi D, Sodani M, Gupta PK, Kulkarni S (2021) Host directed therapies: COVID-19 and beyond. Curr Res Pharmacol Drug Discov 2:100058","journal-title":"Curr Res Pharmacol Drug Discov"},{"key":"11421_CR285","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2024.107130","author":"D Goletti","year":"2024","unstructured":"Goletti D, Ong CWM, Friedland JS (2024) Host-directed therapies: old and new approaches for the treatment of infections. Int J Infect Dis. https:\/\/doi.org\/10.1016\/j.ijid.2024.107130","journal-title":"Int J Infect Dis"},{"issue":"1","key":"11421_CR286","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrd.2017.162","volume":"17","author":"SHE Kaufmann","year":"2018","unstructured":"Kaufmann SHE, Dorhoi A, Hotchkiss RS, Bartenschlager R (2018) Host-directed therapies for bacterial and viral infections. Nat Rev Drug Discov 17(1):35\u201356","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"11421_CR287","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41577-022-00734-z","volume":"23","author":"RS Wallis","year":"2023","unstructured":"Wallis RS, O\u2019Garra A, Sher A, Wack A (2023) Host-directed immunotherapy of viral and bacterial infections: past, present and future. Nat Rev Immunol 23(2):121\u2013133","journal-title":"Nat Rev Immunol"},{"key":"11421_CR288","doi-asserted-by":"publisher","first-page":"1436557","DOI":"10.3389\/fimmu.2024.1436557","volume":"15","author":"RE Thom","year":"2024","unstructured":"Thom RE, D\u2019Elia RV (2024) Future applications of host direct therapies for infectious disease treatment. Front Immunol 15:1436557","journal-title":"Front Immunol"},{"issue":"4","key":"11421_CR289","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1016\/S1473-3099(16)00078-5","volume":"16","author":"A Zumla","year":"2016","unstructured":"Zumla A, Rao M, Wallis RS, Kaufmann SH, Rustomjee R, Mwaba P et al (2016) Host-directed therapies for infectious diseases: current status, recent progress, and future prospects. Lancet Infect Dis 16(4):e47-63","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"11421_CR290","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/CMR.00168-19","volume":"33","author":"N Kumar","year":"2020","unstructured":"Kumar N, Sharma S, Kumar R, Tripathi BN, Barua S, Ly H, Rouse BT (2020) Host-directed antiviral therapy. Clin Microbiol Rev 33(3):10\u20131128","journal-title":"Clin Microbiol Rev"},{"issue":"10","key":"11421_CR291","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1128\/CVI.00148-07","volume":"14","author":"KL Karem","year":"2007","unstructured":"Karem KL, Reynolds M, Hughes C, Braden Z, Nigam P, Crotty S et al (2007) Monkeypox-induced immunity and failure of childhood smallpox vaccination to provide complete protection. Clin Vaccine Immunol 14(10):1318\u20131327","journal-title":"Clin Vaccine Immunol"},{"key":"11421_CR292","doi-asserted-by":"crossref","unstructured":"Vanalli C, Mari L, Casagrandi R, Boag B, Gatto M, Cattadori IM (2022) Modeling the contribution of antibodies to the within-host dynamics of single and dual helminth infections in a natural system. bioRxiv. 2022\u201310","DOI":"10.1101\/2022.10.20.513085"},{"key":"11421_CR293","doi-asserted-by":"publisher","DOI":"10.3390\/ph17050661","author":"D Palazzotti","year":"2024","unstructured":"Palazzotti D, Sguilla M, Manfroni G, Cecchetti V, Astolfi A, Barreca ML (2024) Small molecule drugs targeting viral polymerases. Pharmaceuticals. https:\/\/doi.org\/10.3390\/ph17050661","journal-title":"Pharmaceuticals"},{"issue":"5","key":"11421_CR294","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1002\/jcb.30397","volume":"124","author":"M Dutt","year":"2023","unstructured":"Dutt M, Kumar A, Rout M, Dehury B, Martinez G, Ndishimye P et al (2023) Drug repurposing for Mpox: discovery of small molecules as potential inhibitors against DNA-dependent RNA polymerase using molecular modeling approach. J Cell Biochem 124(5):701\u2013715","journal-title":"J Cell Biochem"},{"key":"11421_CR295","doi-asserted-by":"publisher","first-page":"106057","DOI":"10.1016\/j.antiviral.2024.106057","volume":"234","author":"A Shannon","year":"2025","unstructured":"Shannon A, Canard B (2025) Nucleotide analogues and mpox: repurposing the repurposable. Antiviral Res 234:106057","journal-title":"Antiviral Res"},{"issue":"3","key":"11421_CR296","first-page":"Cd015769","volume":"3","author":"T Fox","year":"2023","unstructured":"Fox T, Gould S, Princy N, Rowland T, Lutje V, Kuehn R (2023) Therapeutics for treating mpox in humans. Cochrane Database Syst Rev 3(3):Cd015769","journal-title":"Cochrane Database Syst Rev"},{"key":"11421_CR297","doi-asserted-by":"publisher","DOI":"10.3390\/v15010251","author":"A Dubey","year":"2023","unstructured":"Dubey A, Alawi MM, Alandijany TA, Alsaady IM, Altwaim SA, Sahoo AK et al (2023) Exploration of microbially derived natural compounds against monkeypox virus as viral core cysteine proteinase inhibitors. Viruses. https:\/\/doi.org\/10.3390\/v15010251","journal-title":"Viruses"},{"issue":"1","key":"11421_CR298","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/cid\/ciac622","volume":"76","author":"EA Siegrist","year":"2022","unstructured":"Siegrist EA, Sassine J (2022) Antivirals with activity against Mpox: a clinically oriented review. Clin Infect Dis 76(1):155\u2013164","journal-title":"Clin Infect Dis"},{"issue":"4","key":"11421_CR299","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1073\/pnas.96.4.1492","volume":"96","author":"LA Loeb","year":"1999","unstructured":"Loeb LA, Essigmann JM, Kazazi F, Zhang J, Rose KD, Mullins JI (1999) Lethal mutagenesis of HIV with mutagenic nucleoside analogs. Proc Natl Acad Sci USA 96(4):1492\u20131497","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"11421_CR300","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.3390\/biomedicines11041106","volume":"11","author":"SA Hudu","year":"2023","unstructured":"Hudu SA, Alshrari AS, Al Qtaitat A, Imran M (2023) VP37 protein inhibitors for Mpox treatment: highlights on recent advances, patent literature, and future directions. Biomedicines 11(4):1106","journal-title":"Biomedicines"},{"issue":"Supplement_1","key":"11421_CR301","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1093\/jpids\/piad059","volume":"13","author":"KG Valencia Deray","year":"2024","unstructured":"Valencia Deray KG, Danziger-Isakov LA, Downes KJ (2024) Current and emerging antiviral agents in the prevention and treatment of cytomegalovirus in pediatric transplant recipients. J Pediatric Infect Dis Soc 13(Supplement_1):S14\u2013S21","journal-title":"J Pediatric Infect Dis Soc"},{"key":"11421_CR302","unstructured":"LiverTox: clinical and research information on drug-induced liver injury. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda (MD), 2012"},{"key":"11421_CR303","doi-asserted-by":"publisher","first-page":"1149909","DOI":"10.3389\/fphar.2023.1149909","volume":"14","author":"MA Shamim","year":"2023","unstructured":"Shamim MA, Satapathy P, Padhi BK, Veeramachaneni SD, Akhtar N, Pradhan A et al (2023) Pharmacological treatment and vaccines in monkeypox virus: a narrative review and bibliometric analysis. Front Pharmacol 14:1149909","journal-title":"Front Pharmacol"},{"key":"11421_CR304","unstructured":"Kawalkar SS, Chavhan SD, Deshmukh HM, Umale ND, Sawarkar H (2024) Assessing cidofovir efficacy in the treatment of emerging monkeypox cases"},{"key":"11421_CR305","doi-asserted-by":"publisher","first-page":"101159","DOI":"10.1016\/j.mam.2022.101159","volume":"88","author":"T Majerov\u00e1","year":"2022","unstructured":"Majerov\u00e1 T, Konvalinka J (2022) Viral proteases as therapeutic targets. Mol Aspects Med 88:101159","journal-title":"Mol Aspects Med"},{"issue":"8","key":"11421_CR306","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1021\/jm049147h","volume":"48","author":"MC Pirrung","year":"2005","unstructured":"Pirrung MC, Pansare SV, Sarma KD, Keith KA, Kern ER (2005) Combinatorial optimization of isatin-beta-thiosemicarbazones as anti-poxvirus agents. J Med Chem 48(8):3045\u20133050","journal-title":"J Med Chem"},{"issue":"2","key":"11421_CR307","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s00044-021-02832-4","volume":"31","author":"T Elsaman","year":"2022","unstructured":"Elsaman T, Mohamed MS, Eltayib EM, Abdel-Aziz HA, Abdalla AE, Munir MU et al (2022) Isatin derivatives as broad-spectrum antiviral agents: the current landscape. Med Chem Res 31(2):244\u2013273","journal-title":"Med Chem Res"},{"issue":"9","key":"11421_CR308","doi-asserted-by":"publisher","first-page":"e0299342","DOI":"10.1371\/journal.pone.0299342","volume":"19","author":"M Hashemi","year":"2024","unstructured":"Hashemi M, Zabihian A, Hajsaeedi M, Hooshmand M (2024) Antivirals for monkeypox virus: proposing an effective machine\/deep learning framework. PLoS ONE 19(9):e0299342","journal-title":"PLoS ONE"},{"key":"#cr-split#-11421_CR309.1","unstructured":"Horton A, Berryman H, Surani YM, Bewley K, Wand ME, Sutton JM, et al (2025) The antiviral activity of licensed therapeutics against Mpox clade Ib, in vitro"},{"key":"#cr-split#-11421_CR309.2","unstructured":"alternative options for the treatment of Mpox. bioRxiv. 2025.01.11.632516"},{"issue":"7","key":"11421_CR310","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1128\/JVI.02346-12","volume":"87","author":"T Baranovich","year":"2013","unstructured":"Baranovich T, Wong SS, Armstrong J, Marjuki H, Webby RJ, Webster RG et al (2013) T-705 (favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitro. J Virol 87(7):3741\u20133751","journal-title":"J Virol"},{"issue":"18","key":"11421_CR311","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1002\/1873-3468.14182","volume":"595","author":"AK Padhi","year":"2021","unstructured":"Padhi AK, Dandapat J, Saudagar P, Uversky VN, Tripathi T (2021) Interface-based design of the favipiravir-binding site in SARS-CoV-2 RNA-dependent RNA polymerase reveals mutations conferring resistance to chain termination. FEBS Lett 595(18):2366\u20132382","journal-title":"FEBS Lett"},{"key":"11421_CR312","doi-asserted-by":"publisher","DOI":"10.7573\/dic.2020-4-14","author":"J Pardo","year":"2020","unstructured":"Pardo J, Shukla AM, Chamarthi G, Gupte A (2020) The journey of remdesivir: from Ebola to COVID-19. Drugs Context. https:\/\/doi.org\/10.7573\/dic.2020-4-14","journal-title":"Drugs Context"},{"issue":"7","key":"11421_CR313","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.tim.2016.03.010","volume":"24","author":"N Kurt Yilmaz","year":"2016","unstructured":"Kurt Yilmaz N, Swanstrom R, Schiffer CA (2016) Improving viral protease inhibitors to counter drug resistance. Trends Microbiol 24(7):547\u2013557","journal-title":"Trends Microbiol"},{"key":"11421_CR314","doi-asserted-by":"crossref","unstructured":"Liu C, Xinyu W, Chuanlie Z, and Cao X (2025) A real-world disproportionality analysis of cidofovir from the FDA Adverse Event Reporting System (FAERS) database. Expert Opin Drug Safety, pp 1\u20139","DOI":"10.1080\/14740338.2025.2490271"},{"key":"11421_CR315","doi-asserted-by":"publisher","first-page":"1144325","DOI":"10.3389\/fpubh.2023.1144325","volume":"11","author":"NM Alorfi","year":"2023","unstructured":"Alorfi NM, Alshehri FS, Haseeb A (2023) Characterization of interventional clinical trials for monkeypox; systematic review of ClinicalTrials.gov database. Front Public Health 11:1144325","journal-title":"Front Public Health"},{"key":"11421_CR316","doi-asserted-by":"publisher","DOI":"10.3390\/v17010092","author":"H Witwit","year":"2025","unstructured":"Witwit H, Cubitt B, Khafaji R, Castro EM, Goicoechea M, Lorenzo MM et al (2025) Repurposing drugs for synergistic combination therapies to counteract monkeypox virus Tecovirimat resistance. Viruses. https:\/\/doi.org\/10.3390\/v17010092","journal-title":"Viruses"},{"issue":"1","key":"11421_CR317","doi-asserted-by":"publisher","first-page":"4660","DOI":"10.1038\/s41467-024-48312-2","volume":"15","author":"R Zhao","year":"2024","unstructured":"Zhao R, Wu L, Sun J, Liu D, Han P, Gao Y et al (2024) Two noncompeting human neutralizing antibodies targeting MPXV B6 show protective effects against orthopoxvirus infections. Nat Commun 15(1):4660","journal-title":"Nat Commun"},{"issue":"2","key":"11421_CR318","doi-asserted-by":"publisher","first-page":"2223669","DOI":"10.1080\/22221751.2023.2223669","volume":"12","author":"M Li","year":"2023","unstructured":"Li M, Ren Z, Wang Y, Jiang Y, Yang M, Li D et al (2023) Three neutralizing mAbs induced by MPXV A29L protein recognizing different epitopes act synergistically against orthopoxvirus. Emerging Microbes Infect 12(2):2223669","journal-title":"Emerging Microbes Infect"},{"issue":"1","key":"11421_CR319","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/antib14010020","volume":"14","author":"VN Nikitin","year":"2025","unstructured":"Nikitin VN, Merkuleva IA, Shcherbakov DN (2025) Monoclonal antibodies in light of Mpox outbreak: current research, therapeutic targets, and animal models. Antibodies 14(1):20","journal-title":"Antibodies"},{"key":"11421_CR320","doi-asserted-by":"publisher","DOI":"10.3390\/v16020308","author":"D Chang","year":"2024","unstructured":"Chang D, Dela Cruz C, Sharma L (2024) Beneficial and detrimental effects of cytokines during influenza and COVID-19. Viruses. https:\/\/doi.org\/10.3390\/v16020308","journal-title":"Viruses"},{"key":"11421_CR321","doi-asserted-by":"publisher","first-page":"902853","DOI":"10.3389\/fimmu.2022.902853","volume":"13","author":"H Amsden","year":"2022","unstructured":"Amsden H, Kourko O, Roth M, Gee K (2022) Antiviral activities of interleukin-27: a partner for interferons? Front Immunol 13:902853","journal-title":"Front Immunol"},{"issue":"5","key":"11421_CR322","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1159\/000495897","volume":"51","author":"SF Li","year":"2018","unstructured":"Li SF, Gong MJ, Zhao FR, Shao JJ, Xie YL, Zhang YG et al (2018) Type I interferons: distinct biological activities and current applications for viral infection. Cell Physiol Biochem 51(5):2377\u20132396","journal-title":"Cell Physiol Biochem"},{"issue":"8","key":"11421_CR323","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1089\/1079990041689665","volume":"24","author":"L Malmgaard","year":"2004","unstructured":"Malmgaard L (2004) Induction and regulation of IFNs during viral infections. J Interferon Cytokine Res 24(8):439\u2013454","journal-title":"J Interferon Cytokine Res"},{"key":"11421_CR324","doi-asserted-by":"publisher","first-page":"106847","DOI":"10.1016\/j.ijsu.2022.106847","volume":"105","author":"S Chakraborty","year":"2022","unstructured":"Chakraborty S, Chandran D, Mohapatra RK, Alagawany M, El-Shall NA, Sharma AK et al (2022) Clinical management, antiviral drugs and immunotherapeutics for treating monkeypox. An update on current knowledge and futuristic prospects. Int J Surg 105:106847","journal-title":"Int J Surg"},{"issue":"12","key":"11421_CR325","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1097\/ICO.0000000000003360","volume":"42","author":"JY Arteaga-Rivera","year":"2023","unstructured":"Arteaga-Rivera JY, Vigderovich-Cielak I, Ramirez-Miranda A, Gonz\u00e1lez A, Fr\u00edas-Jimenez E, Arriaga-Guzman IE et al (2023) Adjuvant topical interferon alpha 2b for the treatment of monkeypox ocular manifestations. Cornea 42(12):1578\u20131581","journal-title":"Cornea"},{"key":"11421_CR326","doi-asserted-by":"publisher","first-page":"156560","DOI":"10.1016\/j.cyto.2024.156560","volume":"177","author":"GB da Silva","year":"2024","unstructured":"da Silva GB, de Carvalho Braga G, Sim\u00f5es JLB, Kempka AP, Bagatini MD (2024) Cytokine storm in human monkeypox: a possible involvement of purinergic signaling. Cytokine 177:156560","journal-title":"Cytokine"},{"key":"11421_CR327","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1743-422X-9-5","volume":"9","author":"SC Johnston","year":"2012","unstructured":"Johnston SC, Lin KL, Connor JH, Ruthel G, Goff A, Hensley LE (2012) In vitro inhibition of monkeypox virus production and spread by interferon-\u03b2. Virol J 9:5","journal-title":"Virol J"},{"key":"11421_CR328","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jcv.2014.12.001","volume":"63","author":"SC Johnston","year":"2015","unstructured":"Johnston SC, Johnson JC, Stonier SW, Lin KL, Kisalu NK, Hensley LE et al (2015) Cytokine modulation correlates with severity of monkeypox disease in humans. J Clin Virol 63:42\u201345","journal-title":"J Clin Virol"},{"issue":"1","key":"11421_CR329","doi-asserted-by":"publisher","first-page":"28306","DOI":"10.1002\/jmv.28306","volume":"95","author":"AA Rabaan","year":"2023","unstructured":"Rabaan AA, Abas AH, Tallei TE, Al-Zaher MA, Al-Sheef NM, Fatimawali et al (2023) Monkeypox outbreak 2022: What we know so far and its potential drug targets and management strategies. J Med Virol 95(1):28306","journal-title":"J Med Virol"},{"issue":"9","key":"11421_CR330","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s40265-022-01742-y","volume":"82","author":"JG Rizk","year":"2022","unstructured":"Rizk JG, Lippi G, Henry BM, Forthal DN, Rizk Y (2022) Prevention and treatment of monkeypox. Drugs 82(9):957\u2013963","journal-title":"Drugs"},{"issue":"4","key":"11421_CR331","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1007\/s11357-022-00611-6","volume":"44","author":"J Quarleri","year":"2022","unstructured":"Quarleri J, Delpino MV, Galvan V (2022) Monkeypox: considerations for the understanding and containment of the current outbreak in non-endemic countries. Geroscience 44(4):2095\u20132103","journal-title":"Geroscience"},{"key":"11421_CR332","doi-asserted-by":"publisher","first-page":"127","DOI":"10.12688\/f1000research.130272.2","volume":"12","author":"SK Ahmed","year":"2023","unstructured":"Ahmed SK, Mohamed MG, Dabou EA, Abuijlan I, Chandran D, El-Shall NA et al (2023) Monkeypox (mpox) in\u00a0immunosuppressed patients. F1000Res 12:127","journal-title":"F1000Res"},{"issue":"1","key":"11421_CR333","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/COC.0000000000000239","volume":"39","author":"EI Buchbinder","year":"2016","unstructured":"Buchbinder EI, Desai A (2016) CTLA-4 and PD-1 pathways: similarities, differences, and implications of their inhibition. Am J Clin Oncol 39(1):98\u2013106","journal-title":"Am J Clin Oncol"},{"key":"11421_CR334","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ijid.2017.01.028","volume":"56","author":"M Rao","year":"2017","unstructured":"Rao M, Valentini D, Dodoo E, Zumla A, Maeurer M (2017) Anti-PD-1\/PD-L1 therapy for infectious diseases: learning from the cancer paradigm. Int J Infect Dis 56:221\u2013228","journal-title":"Int J Infect Dis"},{"issue":"1","key":"11421_CR335","doi-asserted-by":"publisher","first-page":"5186","DOI":"10.1038\/s41467-023-40748-2","volume":"14","author":"S Yang","year":"2023","unstructured":"Yang S, Wang Y, Yu F, Cheng R, Zhang Y, Zhou D et al (2023) Structural and functional insights into the modulation of T cell costimulation by monkeypox virus protein M2. Nat Commun 14(1):5186","journal-title":"Nat Commun"},{"issue":"11","key":"11421_CR336","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","volume":"20","author":"AD Waldman","year":"2020","unstructured":"Waldman AD, Fritz JM, Lenardo MJ (2020) A guide to cancer immunotherapy: from T cell basic science to clinical practice. Nat Rev Immunol 20(11):651\u2013668","journal-title":"Nat Rev Immunol"},{"key":"11421_CR337","doi-asserted-by":"publisher","DOI":"10.3390\/cells11152262","author":"L G\u00f3mez-Virgilio","year":"2022","unstructured":"G\u00f3mez-Virgilio L, Silva-Lucero MD, Flores-Morelos DS, Gallardo-Nieto J, Lopez-Toledo G, Abarca-Fernandez AM et al (2022) Autophagy: a key regulator of homeostasis and disease: an overview of molecular mechanisms and modulators. Cells. https:\/\/doi.org\/10.3390\/cells11152262","journal-title":"Cells"},{"issue":"21","key":"11421_CR338","doi-asserted-by":"publisher","first-page":"4652","DOI":"10.1016\/j.cell.2023.08.023","volume":"186","author":"M Aid","year":"2023","unstructured":"Aid M, Sciacca M, McMahan K, Hope D, Liu J, Jacob-Dolan C et al (2023) Mpox infection protects against re-challenge in rhesus macaques. Cell 186(21):4652\u201361.e13","journal-title":"Cell"},{"key":"11421_CR339","doi-asserted-by":"publisher","first-page":"6683501","DOI":"10.1155\/cjid\/6683501","volume":"2025","author":"S Sankar","year":"2025","unstructured":"Sankar S, Balakrishnan P, Yong YK, Raju S, Velu V, Shankar EM et al (2025) Mpox virus as a global public health emergency: a scoping review. Can J Infect Dis Med Microbiol 2025:6683501","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"2","key":"11421_CR340","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/IM9.0000000000000146","volume":"6","author":"VH Sofiani","year":"2024","unstructured":"Sofiani VH, Rukerd MRZ, Charostad J, Pardeshenas M, Ghazi R, Arefinia N et al (2024) From entry to evasion: a comprehensive analysis of host-virus interactions for monkeypox. Infectious Microbes Dis 6(2):56\u201364","journal-title":"Infectious Microbes Dis"},{"key":"11421_CR341","doi-asserted-by":"publisher","first-page":"766142","DOI":"10.3389\/fcell.2021.766142","volume":"9","author":"S Liang","year":"2021","unstructured":"Liang S, Wu YS, Li DY, Tang JX, Liu HF (2021) Autophagy in viral infection and pathogenesis. Front Cell Dev Biol 9:766142","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"11421_CR342","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3390\/cells2010083","volume":"2","author":"AI Chiramel","year":"2013","unstructured":"Chiramel AI, Brady NR, Bartenschlager R (2013) Divergent roles of autophagy in virus infection. Cells 2(1):83\u2013104","journal-title":"Cells"},{"issue":"5","key":"11421_CR343","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1159\/000346388","volume":"5","author":"X Dong","year":"2013","unstructured":"Dong X, Levine B (2013) Autophagy and viruses: adversaries or allies? J Innate Immun 5(5):480\u2013493","journal-title":"J Innate Immun"},{"issue":"7","key":"11421_CR344","doi-asserted-by":"publisher","first-page":"e2223","DOI":"10.1002\/hsr2.2223","volume":"7","author":"SS Meem","year":"2024","unstructured":"Meem SS, Proma AY, Bhuiyan MA, Dewan SMR (2024) The pressing need for study on the effects of Mpox on the progression of vascular inflammation: a well-timed call. Health Sci Rep 7(7):e2223","journal-title":"Health Sci Rep"},{"issue":"9","key":"11421_CR345","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/jcph.2258","volume":"63","author":"G Marcian\u00f2","year":"2023","unstructured":"Marcian\u00f2 G, Muraca L, Rania V, Gallelli L (2023) Ibuprofen in the management of viral infections: the lesson of COVID-19 for its use in a clinical setting. J Clin Pharmacol 63(9):975\u2013992","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"11421_CR346","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1038\/s41467-018-04574-1","volume":"9","author":"A Singanayagam","year":"2018","unstructured":"Singanayagam A, Glanville N, Girkin JL, Ching YM, Marcellini A, Porter JD et al (2018) Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations. Nat Commun 9(1):2229","journal-title":"Nat Commun"},{"key":"11421_CR347","doi-asserted-by":"publisher","first-page":"9259646","DOI":"10.1155\/2016\/9259646","volume":"2016","author":"P Rider","year":"2016","unstructured":"Rider P, Carmi Y, Cohen I (2016) Biologics for targeting inflammatory cytokines, clinical uses, and limitations. Int J Cell Biol 2016:9259646","journal-title":"Int J Cell Biol"},{"issue":"4","key":"11421_CR348","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00011-016-0996-0","volume":"66","author":"LP Tavares","year":"2017","unstructured":"Tavares LP, Teixeira MM, Garcia CC (2017) The inflammatory response triggered by Influenza virus: a two edged sword. Inflamm Res 66(4):283\u2013302","journal-title":"Inflamm Res"},{"issue":"4","key":"11421_CR349","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/15360288.2023.2250762","volume":"37","author":"M Shabbir","year":"2023","unstructured":"Shabbir M, Bugayong ML, DeVita MA (2023) Mpox pain management with topical agents: a case series. J Pain Palliat Care Pharmacother 37(4):317\u2013320","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"4","key":"11421_CR350","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1080\/15360288.2023.2276930","volume":"37","author":"H Daungsupawong","year":"2023","unstructured":"Daungsupawong H, Wiwanitkit V (2023) Mpox pain management and topical agents. J Pain Palliat Care Pharmacother 37(4):270\u2013271","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"19","key":"11421_CR351","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1001\/jama.2024.21091","volume":"332","author":"BK Titanji","year":"2024","unstructured":"Titanji BK, Hazra A, Zucker J (2024) Mpox clinical presentation, diagnostic approaches, and treatment strategies: a review. JAMA 332(19):1652\u20131662","journal-title":"JAMA"},{"issue":"10","key":"11421_CR352","doi-asserted-by":"publisher","first-page":"e31490","DOI":"10.1016\/j.heliyon.2024.e31490","volume":"10","author":"D Jandrasits","year":"2024","unstructured":"Jandrasits D, Z\u00fcst R, Siegrist D, Engler OB, Weber B, Schmidt KM et al (2024) Third-generation smallpox vaccines induce low-level cross-protecting neutralizing antibodies against Monkeypox virus in laboratory workers. Heliyon 10(10):e31490","journal-title":"Heliyon"},{"key":"11421_CR353","doi-asserted-by":"publisher","first-page":"106971","DOI":"10.1016\/j.ijsu.2022.106971","volume":"107","author":"R Sah","year":"2022","unstructured":"Sah R, Humayun M, Baig E, Farooq M, Hussain HG, Shahid MU et al (2022) FDA\u2019s authorized \u201cJYNNEOS\u201d vaccine for counteracting monkeypox global public health emergency; an update\u2014correspondence. Int J Surg 107:106971","journal-title":"Int J Surg"},{"key":"11421_CR354","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11111708","author":"RM Ghazy","year":"2023","unstructured":"Ghazy RM, Elrewany E, Gebreal A, ElMakhzangy R, Fadl N, Elbanna EH et al (2023) Systematic review on the efficacy, effectiveness, safety, and immunogenicity of monkeypox vaccine. Vaccines. https:\/\/doi.org\/10.3390\/vaccines11111708","journal-title":"Vaccines"},{"key":"11421_CR355","doi-asserted-by":"crossref","unstructured":"Goswami TK, Joardar SN (2025) Are we sure that drug can cure or the vaccine is genuine to restrain mpox to be benign: a brief review. Acta Sci Med Sci (ISSN: 2582\u20130931). 9(1)","DOI":"10.31080\/ASMS.2024.09.1990"},{"issue":"9","key":"11421_CR356","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1093\/infdis\/jir527","volume":"204","author":"JS Kennedy","year":"2011","unstructured":"Kennedy JS, Gurwith M, Dekker CL, Frey SE, Edwards KM, Kenner J et al (2011) Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults. J Infect Dis 204(9):1395\u20131402","journal-title":"J Infect Dis"},{"key":"11421_CR357","doi-asserted-by":"publisher","first-page":"106898","DOI":"10.1016\/j.ijsu.2022.106898","volume":"105","author":"FM Dayyab","year":"2022","unstructured":"Dayyab FM, Daiyab HM, Farahat RA (2022) Precautions and recommendations towards possible cardiac manifestations of monkeypox vaccination. Int J Surg 105:106898","journal-title":"Int J Surg"},{"issue":"1","key":"11421_CR358","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1080\/14760584.2024.2397006","volume":"23","author":"JD Grabenstein","year":"2024","unstructured":"Grabenstein JD, Hacker A (2024) Vaccines against mpox: MVA-BN and LC16m8. Expert Rev Vaccines 23(1):796\u2013811","journal-title":"Expert Rev Vaccines"},{"issue":"4","key":"11421_CR359","first-page":"332","volume":"111","author":"SE Frey","year":"2014","unstructured":"Frey SE (2014) New smallpox vaccines for an ancient scourge. Mo Med 111(4):332\u2013336","journal-title":"Mo Med"},{"issue":"Rr-02","key":"11421_CR360","first-page":"1","volume":"64","author":"BW Petersen","year":"2015","unstructured":"Petersen BW, Damon IK, Pertowski CA, Meaney-Delman D, Guarnizo JT, Beigi RH et al (2015) Clinical guidance for smallpox vaccine use in a postevent vaccination program. MMWR Recomm Rep 64(Rr-02):1\u201326","journal-title":"MMWR Recomm Rep"},{"issue":"5","key":"11421_CR361","doi-asserted-by":"publisher","first-page":"e0300778","DOI":"10.1371\/journal.pone.0300778","volume":"19","author":"AT Moin","year":"2024","unstructured":"Moin AT, Rani NA, Patil RB, Robin TB, Ullah MA, Rahim Z et al (2024) In-silico formulation of a next-generation polyvalent vaccine against multiple strains of monkeypox virus and other related poxviruses. PLoS ONE 19(5):e0300778","journal-title":"PLoS ONE"},{"key":"11421_CR362","doi-asserted-by":"publisher","first-page":"1295817","DOI":"10.3389\/fmolb.2023.1295817","volume":"10","author":"A Choudhury","year":"2023","unstructured":"Choudhury A, Chandra A, Dawoud TM, Nafidi HA, Singh N, Bourhia M (2023) Immunoinformatics and reverse vaccinology approach in designing a novel highly immunogenic multivalent peptide-based vaccine against the human monkeypox virus. Front Mol Biosci 10:1295817","journal-title":"Front Mol Biosci"},{"issue":"9","key":"11421_CR363","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.3390\/vaccines10091564","volume":"10","author":"SAH Abdi","year":"2022","unstructured":"Abdi SAH, Ali A, Sayed SF, Abutahir, Ali A, Alam P (2022) Multi-epitope-based vaccine candidate for monkeypox: an in silico approach. Vaccines 10(9):1564","journal-title":"Vaccines"},{"key":"11421_CR364","unstructured":"Alishavandi A, Shekari T, Yazdi MH (eds) (2024) In silico design of a recombinant multi-epitope vaccine against non-small cell lung cancer (NSCLC) via advanced immunoinformatics and reverse vaccinology approaches. Eur J Hum Genet. Springernature Campus, 4 Crinan St, London, N1 9xw, England"},{"issue":"16","key":"11421_CR365","doi-asserted-by":"publisher","first-page":"e36154","DOI":"10.1016\/j.heliyon.2024.e36154","volume":"10","author":"A Kaur","year":"2024","unstructured":"Kaur A, Kumar A, Kumari G, Muduli R, Das M, Kundu R et al (2024) Rational design and computational evaluation of a multi-epitope vaccine for monkeypox virus: insights into binding stability and immunological memory. Heliyon 10(16):e36154","journal-title":"Heliyon"},{"key":"11421_CR366","doi-asserted-by":"publisher","first-page":"1091941","DOI":"10.3389\/fimmu.2023.1091941","volume":"14","author":"M Waqas","year":"2023","unstructured":"Waqas M, Aziz S, Li\u00f2 P, Khan Y, Ali A, Iqbal A et al (2023) Immunoinformatics design of multivalent epitope vaccine against monkeypox virus and its variants using membrane-bound, enveloped, and extracellular proteins as targets. Front Immunol 14:1091941","journal-title":"Front Immunol"},{"key":"11421_CR367","doi-asserted-by":"publisher","DOI":"10.3390\/v15051120","author":"N Rcheulishvili","year":"2023","unstructured":"Rcheulishvili N, Mao J, Papukashvili D, Feng S, Liu C, Yang X et al (2023) Development of a multi-epitope universal mRNA vaccine candidate for monkeypox, smallpox, and vaccinia viruses: design and in silico analyses. Viruses. https:\/\/doi.org\/10.3390\/v15051120","journal-title":"Viruses"},{"issue":"6","key":"11421_CR368","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.3390\/biomedicines13061439","volume":"13","author":"MA Izhari","year":"2025","unstructured":"Izhari MA, Alharthi SB, Alharbi RA, Almontasheri AHA, Alghamdi WA, Sindi AAA et al (2025) Design and validation of a multi-epitope mRNA vaccine construct against human monkeypox virus (hMPXV) by annotating protein of intracellular mature virus (IMV) form of hMPXV. Biomedicines 13(6):1439","journal-title":"Biomedicines"},{"issue":"14","key":"11421_CR369","doi-asserted-by":"publisher","first-page":"1091941","DOI":"10.3389\/fimmu.2023.1091941","volume":"26","author":"M Waqas","year":"2023","unstructured":"Waqas M, Aziz S, Li\u00f2 P, Khan Y, Ali A, Iqbal A, Khan F, Almajhdi FN (2023) Immunoinformatics design of multivalent epitope vaccine against monkeypox virus and its variants using membrane-bound, enveloped, and extracellular proteins as targets. Front Immunol 26(14):1091941","journal-title":"Front Immunol"},{"key":"11421_CR370","unstructured":"Cena A, Kiarash S, Amirreza M, Maryam B, Nima R. (2025). Unraveling the M1R protein of monkeypox virus: an integrated structural bioinformatics, immunological profiling, and molecular dynamics simulation approach. Immunol Genet J. 8(4)"},{"key":"11421_CR371","doi-asserted-by":"publisher","first-page":"107691","DOI":"10.1016\/j.micpath.2025.107691","volume":"205","author":"A Alishvandi","year":"2025","unstructured":"Alishvandi A, Barancheshemeh M, Firuzpour F, Aram C, Kamali MJ, Keikha M (2025) Decoding virulence and resistance in Klebsiella pneumoniae: pharmacological insights, immunological dynamics, and in silico therapeutic strategies. Microb Pathog 205:107691","journal-title":"Microb Pathog"},{"issue":"1","key":"11421_CR372","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1186\/s12879-024-09332-x","volume":"24","author":"T Loganathan","year":"2024","unstructured":"Loganathan T, Fletcher J, Abraham P, kannangai R, Chakraborty C, El Allali A et al (2024) Expression analysis and mapping of viral\u2014host protein interactions of Poxviridae suggests a lead candidate molecule targeting Mpox. BMC Infect Dis 24(1):483","journal-title":"BMC Infect Dis"},{"key":"11421_CR373","doi-asserted-by":"publisher","DOI":"10.1097\/IM9.0000000000000146","author":"VH Sofiani","year":"2024","unstructured":"Sofiani VH, Rukerd MRZ, Charostad J, Pardeshenas M, Ghazi R, Arefinia N et al (2024) From entry to evasion: a comprehensive analysis of host-virus interactions for monkeypox. Infect Microbes Dis. https:\/\/doi.org\/10.1097\/IM9.0000000000000146","journal-title":"Infect Microbes Dis"},{"issue":"5","key":"11421_CR374","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jtct.2023.01.030","volume":"29","author":"ES Ford","year":"2023","unstructured":"Ford ES, Papanicolaou GA, Dadwal SS, Pergam S, Spallone A (2023) Frequently asked questions about Mpox (formerly Monkeypox disease) for hematopoietic cell transplantation and chimeric antigen receptor T cell recipients from the American Society for Transplantation and Cellular Therapy. Transplant Cell Ther 29(5):289\u2013292","journal-title":"Transplant Cell Ther"},{"issue":"9","key":"11421_CR375","first-page":"e44687","volume":"15","author":"T Dubey","year":"2023","unstructured":"Dubey T, Chakole S, Agrawal S, Gupta A, Munjewar PK, Sharma R et al (2023) Enhancing nursing care in monkeypox (mpox) patients: differential diagnoses, prevention measures, and therapeutic interventions. Cureus 15(9):e44687","journal-title":"Cureus"},{"issue":"3","key":"11421_CR376","first-page":"529","volume":"71","author":"EAD Hammershaimb","year":"2024","unstructured":"Hammershaimb EAD, Campbell JD (2024) Vaccine development. Pediatr Clin 71(3):529\u2013549","journal-title":"Pediatr Clin"},{"key":"11421_CR377","doi-asserted-by":"publisher","first-page":"251513552513143","DOI":"10.1177\/25151355251314339","volume":"13","author":"M Shafaati","year":"2025","unstructured":"Shafaati M, Forghani S, Shahsavand Davoudi A, Samiee R, Mohammadi K, Akbarpour S et al (2025) Current advances and challenges in mpox vaccine development: a global landscape. Ther Adv Vaccines Immunother 13:25151355251314340","journal-title":"Ther Adv Vaccines Immunother"},{"issue":"3","key":"11421_CR378","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.vaccine.2023.12.066","volume":"42","author":"JB Rosen","year":"2024","unstructured":"Rosen JB, Arciuolo RJ, Pathela P, Boyer CB, Baumgartner J, Latash J et al (2024) JYNNEOS\u2122 effectiveness as post-exposure prophylaxis against mpox: challenges using real-world outbreak data. Vaccine 42(3):548\u2013555","journal-title":"Vaccine"},{"issue":"12","key":"11421_CR379","doi-asserted-by":"publisher","first-page":"e349","DOI":"10.1016\/S1473-3099(22)00574-6","volume":"22","author":"GA Poland","year":"2022","unstructured":"Poland GA, Kennedy RB, Tosh PK (2022) Prevention of monkeypox with vaccines: a rapid review. Lancet Infect Dis 22(12):e349\u2013e358","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"11421_CR380","doi-asserted-by":"publisher","first-page":"e01164","DOI":"10.1002\/prp2.1164","volume":"12","author":"F Pourkarim","year":"2024","unstructured":"Pourkarim F, Entezari-Maleki T (2024) Clinical considerations on monkeypox antiviral medications: an overview. Pharmacol Res Perspect 12(1):e01164","journal-title":"Pharmacol Res Perspect"},{"issue":"5","key":"11421_CR381","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1080\/17460441.2023.2199980","volume":"18","author":"AA Ezat","year":"2023","unstructured":"Ezat AA, M. AJ, M. EA, Ahmed S, Elfiky AA (2023) The discovery of novel antivirals for the treatment of mpox: is drug repurposing the answer? Expert Opin Drug Discov 18(5):551\u2013561","journal-title":"Expert Opin Drug Discov"},{"issue":"9","key":"11421_CR382","doi-asserted-by":"publisher","first-page":"e70069","DOI":"10.1002\/hsr2.70069","volume":"7","author":"AM Taha","year":"2024","unstructured":"Taha AM, Mahmoud AM, Abouelmagd K, Saed SAA, Khalefa BB, Shah S et al (2024) Effectiveness of a single dose of JYNNEOS vaccine in real world: a systematic review and meta-analysis. Health Sci Rep 7(9):e70069","journal-title":"Health Sci Rep"},{"issue":"26","key":"11421_CR383","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1056\/NEJMoa2215201","volume":"388","author":"NP Deputy","year":"2023","unstructured":"Deputy NP, Deckert J, Chard AN, Sandberg N, Moulia DL, Barkley E et al (2023) Vaccine effectiveness of JYNNEOS against Mpox disease in the United States. N Engl J Med 388(26):2434\u20132443","journal-title":"N Engl J Med"},{"key":"11421_CR384","unstructured":"Interim clinical considerations for use of vaccine for monkeypox prevention in the United States 2025 [Available from: https:\/\/www.cdc.gov\/monkeypox\/hcp\/vaccine-considerations\/vaccination-overview.html"},{"key":"11421_CR385","unstructured":"Evidence to recommendations (EtR) framework for use of JYNNEOS in persons aged \u226518 years at risk for mpox during the ongoing clade iib outbreak 2025 [Available from: https:\/\/www.cdc.gov\/acip\/evidence-to-recommendations\/mpox-vaccine-18-years-and-older-at-risk-clade-IIb-outbreak.html"},{"key":"11421_CR386","unstructured":"(WHO) WHO. WHO prequalifies the first vaccine against mpox 2024 [Available from: https:\/\/www.who.int\/news\/item\/13-09-2024-who-prequalifies-the-first-vaccine-against-mpox"},{"issue":"11","key":"11421_CR387","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.3201\/eid2811.221215","volume":"28","author":"M Turner","year":"2022","unstructured":"Turner M, Mandia J, Keltner C, Haynes R, Faestel P, Mease L (2022) Monkeypox in patient immunized with ACAM2000 smallpox vaccine during 2022 outbreak. Emerg Infect Dis 28(11):2336\u20132338","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"11421_CR388","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/s41541-025-01193-y","volume":"10","author":"F Xu","year":"2025","unstructured":"Xu F, Huang Y, Hou Y, Xie Y, Huang B, Zhao F et al (2025) A new attenuated and highly immunogenic orthopoxvirus vaccine protects against mpox in mice and macaques. Npj Vaccines 10(1):134","journal-title":"Npj Vaccines"},{"key":"11421_CR389","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10091419","author":"A Abdelaal","year":"2022","unstructured":"Abdelaal A, Reda A, Lashin BI, Katamesh BE, Brakat AM, Al-Manaseer BM et al (2022) Preventing the next pandemic: is live vaccine efficacious against monkeypox, or is there a need for killed virus and mRNA vaccines? Vaccines. https:\/\/doi.org\/10.3390\/vaccines10091419","journal-title":"Vaccines"},{"issue":"1","key":"11421_CR390","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s44197-025-00432-8","volume":"15","author":"M Wahid","year":"2025","unstructured":"Wahid M, Mandal RK, Sikander M, Khan MR, Haque S, Nagda N et al (2025) Safety and efficacy of repurposed smallpox vaccines against Mpox: a critical review of ACAM2000, JYNNEOS, and LC16. J Epidemiol Glob Health 15(1):88","journal-title":"J Epidemiol Glob Health"},{"issue":"1","key":"11421_CR391","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12982-024-00229-3","volume":"21","author":"RBO Ouma","year":"2024","unstructured":"Ouma RBO, Ngari SM, Kibet JK (2024) A review of the current trends in computational approaches in drug design and metabolism. Discover Public Health 21(1):108","journal-title":"Discover Public Health"},{"key":"11421_CR392","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/978-981-15-6815-2_6","volume-title":"Computer-aided drug design","author":"S Agnihotry","year":"2020","unstructured":"Agnihotry S, Pathak RK, Srivastav A, Shukla PK, Gautam B (2020) Molecular docking and structure-based drug design. Computer-aided drug design. Singapore, Springer Singapore, pp 115\u2013131"},{"key":"11421_CR393","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/B978-0-12-816125-8.00006-7","volume-title":"Silico drug design","author":"S Kumar","year":"2019","unstructured":"Kumar S, Kumar S (2019) Molecular docking: a structure-based approach for drug repurposing. Silico drug design. Academic Press, pp 161\u2013189"},{"issue":"1","key":"11421_CR394","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3390\/pr9010071","volume":"9","author":"OM Salo-Ahen","year":"2020","unstructured":"Salo-Ahen OM, Alanko I, Bhadane R, Bonvin AM, Honorato RV, Hossain S et al (2020) Molecular dynamics simulations in drug discovery and pharmaceutical development. Processes 9(1):71","journal-title":"Processes"},{"issue":"3","key":"11421_CR395","doi-asserted-by":"publisher","first-page":"e1393","DOI":"10.1002\/wcms.1393","volume":"9","author":"DJ Huggins","year":"2019","unstructured":"Huggins DJ, Biggin PC, D\u00e4mgen MA, Essex JW, Harris SA, Henchman RH et al (2019) Biomolecular simulations: from dynamics and mechanisms to computational assays of biological activity. WIREs Comput Mol Sci 9(3):e1393","journal-title":"WIREs Comput Mol Sci"},{"key":"11421_CR396","doi-asserted-by":"publisher","first-page":"106324","DOI":"10.1016\/j.ejps.2022.106324","volume":"181","author":"D Vemula","year":"2023","unstructured":"Vemula D, Jayasurya P, Sushmitha V, Kumar YN, Bhandari V (2023) CADD, AI and ML in drug discovery: a comprehensive review. Eur J Pharm Sci 181:106324","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"11421_CR397","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00214-022-02878-6","volume":"141","author":"M Yusef Buey","year":"2022","unstructured":"Yusef Buey M, Mineva T, Rapacioli M (2022) Coupling density functional based tight binding with class 1 force fields in a hybrid QM\/MM scheme. Theor Chem Acc 141(3):16","journal-title":"Theor Chem Acc"},{"key":"11421_CR398","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3389\/fchem.2020.00726","volume":"8","author":"F Wu","year":"2020","unstructured":"Wu F, Zhou Y, Li L, Shen X, Chen G, Wang X et al (2020) Computational approaches in preclinical studies on drug discovery and development. Front Chem 8:726","journal-title":"Front Chem"},{"issue":"5","key":"11421_CR399","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.drudis.2019.03.015","volume":"24","author":"LL Ferreira","year":"2019","unstructured":"Ferreira LL, Andricopulo AD (2019) ADMET modeling approaches in drug discovery. Drug Discov Today 24(5):1157\u20131165","journal-title":"Drug Discov Today"},{"issue":"10","key":"11421_CR400","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1080\/07391102.2018.1495576","volume":"37","author":"Y Hu","year":"2019","unstructured":"Hu Y, Zhou L, Zhu X, Dai D, Bao Y, Qiu Y (2019) Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors. J Biomol Struct Dyn 37(10):2703\u20132715","journal-title":"J Biomol Struct Dyn"},{"issue":"7","key":"11421_CR401","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1080\/07391102.2018.1464958","volume":"37","author":"JM Jayaraj","year":"2019","unstructured":"Jayaraj JM, Krishnasamy G, Lee J-K, Muthusamy K (2019) In silico identification and screening of CYP24A1 inhibitors: 3D QSAR pharmacophore mapping and molecular dynamics analysis. J Biomol Struct Dyn 37(7):1700\u20131714","journal-title":"J Biomol Struct Dyn"},{"key":"11421_CR402","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s11224-020-01628-3","volume":"32","author":"U Panwar","year":"2021","unstructured":"Panwar U, Singh SK (2021) Atom-based 3D-QSAR, molecular docking, DFT, and simulation studies of acylhydrazone, hydrazine, and diazene derivatives as IN-LEDGF\/p75 inhibitors. Struct Chem 32:337\u2013352","journal-title":"Struct Chem"},{"issue":"2","key":"11421_CR403","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1021\/acs.chemrestox.0c00224","volume":"34","author":"C de Bruyn Kops","year":"2020","unstructured":"de Bruyn Kops C, \u0160\u00edcho M, Mazzolari A, Kirchmair J (2020) GLORYx: prediction of the metabolites resulting from phase 1 and phase 2 biotransformations of xenobiotics. Chem Res Toxicol 34(2):286\u2013299","journal-title":"Chem Res Toxicol"},{"key":"11421_CR404","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1007\/s00414-020-02387-w","volume":"134","author":"C Hassenberg","year":"2020","unstructured":"Hassenberg C, Clausen F, Hoffmann G, Studer A, Sch\u00fcrenkamp J (2020) Investigation of phase II metabolism of 11-hydroxy-\u0394-9-tetrahydrocannabinol and metabolite verification by chemical synthesis of 11-hydroxy-\u0394-9-tetrahydrocannabinol-glucuronide. Int J Legal Med 134:2105\u20132119","journal-title":"Int J Legal Med"},{"issue":"1","key":"11421_CR405","doi-asserted-by":"publisher","first-page":"40","DOI":"10.2174\/18755453MTEyCOTgcx","volume":"22","author":"J Guo","year":"2021","unstructured":"Guo J, Zhu X, Badawy S, Ihsan A, Liu Z, Xie C et al (2021) Metabolism and mechanism of human cytochrome P450 enzyme 1A2. Curr Drug Metab 22(1):40\u201349","journal-title":"Curr Drug Metab"},{"key":"11421_CR406","unstructured":"Mohsin N, Farrukh M, Shahzadi S, Irfan M (2024) Drug metabolism: phase I and phase II metabolic pathways"},{"issue":"D1","key":"11421_CR407","doi-asserted-by":"publisher","first-page":"D930","DOI":"10.1093\/nar\/gky1075","volume":"47","author":"D Mendez","year":"2019","unstructured":"Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, F\u00e9lix E et al (2019) ChEMBL: towards direct deposition of bioassay data. Nucleic Acids Res 47(D1):D930\u2013D940","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"11421_CR408","doi-asserted-by":"publisher","first-page":"167514","DOI":"10.1016\/j.jmb.2022.167514","volume":"434","author":"S Kim","year":"2022","unstructured":"Kim S, Cheng T, He S, Thiessen PA, Li Q, Gindulyte A et al (2022) PubChem protein, gene, pathway, and taxonomy data collections: bridging biology and chemistry through target-centric views of PubChem data. J Mol Biol 434(11):167514","journal-title":"J Mol Biol"},{"issue":"D1","key":"11421_CR409","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR et al (2018) DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res 46(D1):D1074\u2013D1082","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"11421_CR410","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","volume":"83","author":"DJ Newman","year":"2020","unstructured":"Newman DJ, Cragg GM (2020) Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019. J Nat Prod 83(3):770\u2013803","journal-title":"J Nat Prod"},{"issue":"6","key":"11421_CR411","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s13659-021-00317-w","volume":"11","author":"OT Ebob","year":"2021","unstructured":"Ebob OT, Babiaka SB, Ntie-Kang F (2021) Natural products as potential lead compounds for drug discovery against SARS-CoV-2. Nat Prod Bioprospect 11(6):611\u2013628","journal-title":"Nat Prod Bioprospect"},{"issue":"9","key":"11421_CR412","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1038\/s41587-020-0502-7","volume":"38","author":"M Duran-Frigola","year":"2020","unstructured":"Duran-Frigola M, Pauls E, Guitart-Pla O, Bertoni M, Alcalde V, Amat D et al (2020) Extending the small-molecule similarity principle to all levels of biology with the Chemical Checker. Nat Biotechnol 38(9):1087\u20131096","journal-title":"Nat Biotechnol"},{"issue":"10","key":"11421_CR413","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.7150\/ijbs.59296","volume":"17","author":"R Luo","year":"2021","unstructured":"Luo R, Liu M, Tan T, Yang Q, Wang Y, Men L et al (2021) Emerging significance and therapeutic potential of extracellular vesicles. Int J Biol Sci 17(10):2476","journal-title":"Int J Biol Sci"},{"issue":"W1","key":"11421_CR414","doi-asserted-by":"publisher","first-page":"W5","DOI":"10.1093\/nar\/gkab255","volume":"49","author":"G Xiong","year":"2021","unstructured":"Xiong G, Wu Z, Yi J, Fu L, Yang Z, Hsieh C et al (2021) ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res 49(W1):W5\u2013W14","journal-title":"Nucleic Acids Res"},{"key":"11421_CR415","doi-asserted-by":"publisher","first-page":"105740","DOI":"10.1016\/j.antiviral.2023.105740","volume":"220","author":"PP Parvatikar","year":"2023","unstructured":"Parvatikar PP, Patil S, Khaparkhuntikar K, Patil S, Singh PK, Sahana R et al (2023) Artificial intelligence: machine learning approach for screening large database and drug discovery. Antiviral Res 220:105740","journal-title":"Antiviral Res"},{"issue":"1","key":"11421_CR416","doi-asserted-by":"publisher","first-page":"100039","DOI":"10.1016\/j.aichem.2023.100039","volume":"2","author":"S Singh","year":"2024","unstructured":"Singh S, Gupta H, Sharma P, Sahi S (2024) Advances in Artificial Intelligence (AI)-assisted approaches in drug screening. Artif Intell Chem 2(1):100039","journal-title":"Artif Intell Chem"},{"key":"11421_CR417","doi-asserted-by":"publisher","first-page":"154481","DOI":"10.1016\/j.phymed.2022.154481","volume":"107","author":"Y Lin","year":"2022","unstructured":"Lin Y, Zhang Y, Wang D, Yang B, Shen Y-Q (2022) Computer especially AI-assisted drug virtual screening and design in traditional Chinese medicine. Phytomedicine 107:154481","journal-title":"Phytomedicine"},{"key":"11421_CR418","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13321-016-0157-z","volume":"8","author":"A Dilip","year":"2016","unstructured":"Dilip A, Le\u0161nik S, \u0160tular T, Jane\u017ei\u010d D, Konc J (2016) Ligand-based virtual screening interface between PyMOL and LiSiCA. J Cheminform 8:1\u20135","journal-title":"J Cheminform"},{"key":"11421_CR419","doi-asserted-by":"publisher","first-page":"113165","DOI":"10.1016\/j.ejmech.2021.113165","volume":"213","author":"R Bai","year":"2021","unstructured":"Bai R, Yao C, Zhong Z, Ge J, Bai Z, Ye X et al (2021) Discovery of natural anti-inflammatory alkaloids: potential leads for the drug discovery for the treatment of inflammation. Eur J Med Chem 213:113165","journal-title":"Eur J Med Chem"},{"key":"11421_CR420","doi-asserted-by":"publisher","first-page":"106957","DOI":"10.1016\/j.bioorg.2023.106957","volume":"142","author":"Z Hui","year":"2024","unstructured":"Hui Z, Wen H, Zhu J, Deng H, Jiang X, Ye X-Y et al (2024) Discovery of plant-derived anti-tumor natural products: potential leads for anti-tumor drug discovery. Bioorg Chem 142:106957","journal-title":"Bioorg Chem"},{"issue":"11","key":"11421_CR421","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1080\/17425255.2021.1998454","volume":"17","author":"EE Litsa","year":"2021","unstructured":"Litsa EE, Das P, Kavraki LE (2021) Machine learning models in the prediction of drug metabolism: challenges and future perspectives. Expert Opin Drug Metab Toxicol 17(11):1245\u20131247","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"10","key":"11421_CR422","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s42256-020-00236-4","volume":"2","author":"J Jim\u00e9nez-Luna","year":"2020","unstructured":"Jim\u00e9nez-Luna J, Grisoni F, Schneider G (2020) Drug discovery with explainable artificial intelligence. Nat Mach Intell 2(10):573\u2013584","journal-title":"Nat Mach Intell"},{"issue":"15","key":"11421_CR423","doi-asserted-by":"publisher","first-page":"eabe4166","DOI":"10.1126\/sciadv.abe4166","volume":"7","author":"P Schwaller","year":"2021","unstructured":"Schwaller P, Hoover B, Reymond J-L, Strobelt H, Laino T (2021) Extraction of organic chemistry grammar from unsupervised learning of chemical reactions. Sci Adv 7(15):eabe4166","journal-title":"Sci Adv"},{"issue":"4","key":"11421_CR424","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.drudis.2021.11.023","volume":"27","author":"R Vijayan","year":"2022","unstructured":"Vijayan R, Kihlberg J, Cross JB, Poongavanam V (2022) Enhancing preclinical drug discovery with artificial intelligence. Drug Discov Today 27(4):967\u2013984","journal-title":"Drug Discov Today"},{"key":"11421_CR425","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s11030-021-10217-3","volume":"25","author":"R Gupta","year":"2021","unstructured":"Gupta R, Srivastava D, Sahu M, Tiwari S, Ambasta RK, Kumar P (2021) Artificial intelligence to deep learning: machine intelligence approach for drug discovery. Mol Divers 25:1315\u20131360","journal-title":"Mol Divers"},{"issue":"3","key":"11421_CR426","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.imed.2021.10.001","volume":"2","author":"V Patel","year":"2022","unstructured":"Patel V, Shah M (2022) Artificial intelligence and machine learning in drug discovery and development. Intell Med 2(3):134\u2013140","journal-title":"Intell Med"},{"issue":"5","key":"11421_CR427","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41573-019-0050-3","volume":"19","author":"P Schneider","year":"2020","unstructured":"Schneider P, Walters WP, Plowright AT, Sieroka N, Listgarten J, Goodnow RA Jr et al (2020) Rethinking drug design in the artificial intelligence era. Nat Rev Drug Discov 19(5):353\u2013364","journal-title":"Nat Rev Drug Discov"},{"key":"11421_CR428","doi-asserted-by":"publisher","first-page":"120333","DOI":"10.1016\/j.techfore.2020.120333","volume":"161","author":"OA Belousova","year":"2020","unstructured":"Belousova OA, Groen AJ, Ouendag AM (2020) Opportunities and barriers for innovation and entrepreneurship in orphan drug development. Technol Forecast Soc Change 161:120333","journal-title":"Technol Forecast Soc Change"},{"issue":"3","key":"11421_CR429","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1017\/S0963180122000445","volume":"33","author":"G Starke","year":"2024","unstructured":"Starke G, Ienca M (2024) Misplaced trust and distrust: how not to engage with medical artificial intelligence. Camb Q Healthc Ethics 33(3):360\u2013369","journal-title":"Camb Q Healthc Ethics"},{"key":"11421_CR430","doi-asserted-by":"publisher","DOI":"10.3390\/biom14060692","author":"P Du","year":"2024","unstructured":"Du P, Fan R, Zhang N, Wu C, Zhang Y (2024) Advances in integrated multi-omics analysis for drug-target identification. Biomolecules. https:\/\/doi.org\/10.3390\/biom14060692","journal-title":"Biomolecules"},{"issue":"7","key":"11421_CR431","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13073-014-0057-7","volume":"6","author":"J Jeon","year":"2014","unstructured":"Jeon J, Nim S, Teyra J, Datti A, Wrana JL, Sidhu SS et al (2014) A systematic approach to identify novel cancer drug targets using machine learning, inhibitor design and high-throughput screening. Genome Med 6(7):57","journal-title":"Genome Med"},{"issue":"12","key":"11421_CR432","doi-asserted-by":"publisher","first-page":"e11462","DOI":"10.15252\/msb.202211462","volume":"19","author":"I Pinheiro-de-Sousa","year":"2023","unstructured":"Pinheiro-de-Sousa I, Fonseca-Alaniz MH, Giudice G, Valad\u00e3o IC, Modestia SM, Mattioli SV et al (2023) Integrated systems biology approach identifies gene targets for endothelial dysfunction. Mol Syst Biol 19(12):e11462","journal-title":"Mol Syst Biol"},{"issue":"9","key":"11421_CR433","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1038\/s12276-020-0420-2","volume":"52","author":"J Lee","year":"2020","unstructured":"Lee J, Hyeon DY, Hwang D (2020) Single-cell multiomics: technologies and data analysis methods. Exp Mol Med 52(9):1428\u20131442","journal-title":"Exp Mol Med"},{"issue":"1","key":"11421_CR434","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.cell.2020.06.013","volume":"182","author":"MA Gillette","year":"2020","unstructured":"Gillette MA, Satpathy S, Cao S, Dhanasekaran SM, Vasaikar SV, Krug K et al (2020) Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma. Cell 182(1):200\u201325.e35","journal-title":"Cell"},{"key":"11421_CR435","doi-asserted-by":"publisher","first-page":"1351737","DOI":"10.3389\/fcimb.2024.1351737","volume":"14","author":"CN Ashley","year":"2024","unstructured":"Ashley CN, Broni E, Wood CM, Okuneye T, Ojukwu MT, Dong Q et al (2024) Identifying potential monkeypox virus inhibitors: an in silico study targeting the A42R protein. Front Cell Infect Microbiol 14:1351737","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"11421_CR436","doi-asserted-by":"publisher","first-page":"14570","DOI":"10.1038\/s41598-023-41820-z","volume":"13","author":"TA Alandijany","year":"2023","unstructured":"Alandijany TA, El-Daly MM, Tolah AM, Bajrai LH, Khateb AM, Kumar GS et al (2023) A multi-targeted computational drug discovery approach for repurposing tetracyclines against monkeypox virus. Sci Rep 13(1):14570","journal-title":"Sci Rep"},{"issue":"5","key":"11421_CR437","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1007\/s11030-022-10550-1","volume":"27","author":"AK Sahoo","year":"2023","unstructured":"Sahoo AK, Augusthian PD, Muralitharan I, Vivek-Ananth RP, Kumar K, Kumar G et al (2023) In silico identification of potential inhibitors of vital monkeypox virus proteins from FDA approved drugs. Mol Divers 27(5):2169\u20132184","journal-title":"Mol Divers"},{"issue":"11","key":"11421_CR438","doi-asserted-by":"publisher","first-page":"105241","DOI":"10.1016\/j.arabjc.2023.105241","volume":"16","author":"S Akash","year":"2023","unstructured":"Akash S, Bibi S, Yousafi Q, Ihsan A, Mustafa R, Farooq U et al (2023) Ligand-based drug design of Pinocembrin derivatives against Monkey-Pox disease. Arab J Chem 16(11):105241","journal-title":"Arab J Chem"},{"issue":"16","key":"11421_CR439","doi-asserted-by":"publisher","first-page":"8242","DOI":"10.1080\/07391102.2023.2245041","volume":"42","author":"S Podduturi","year":"2024","unstructured":"Podduturi S, Divya V, Siva S, Bhandari V (2024) In-silico investigation of E8 surface protein of the monkeypox virus to identify potential therapeutic agents. J Biomol Struct Dyn 42(16):8242\u20138255","journal-title":"J Biomol Struct Dyn"},{"key":"11421_CR440","doi-asserted-by":"publisher","first-page":"117793222211411","DOI":"10.1177\/11779322221141164","volume":"16","author":"MM Miah","year":"2022","unstructured":"Miah MM, Tabassum N, Afroj Zinnia M, Islam ABMMK (2022) Drug and anti-viral peptide design to inhibit the Monkeypox virus by restricting A36R protein. Bioinform Biol Insights 16:11779322221141164","journal-title":"Bioinform Biol Insights"},{"issue":"1","key":"11421_CR441","first-page":"9919776","volume":"2023","author":"A Banik","year":"2023","unstructured":"Banik A, Ahmed SR, Shahid SB, Ahmed T, Tamanna HK, Marma H (2023) Therapeutic promises of plant metabolites against Monkeypox Virus: an in silico study. Adv Virol 2023(1):9919776","journal-title":"Adv Virol"},{"issue":"3","key":"11421_CR442","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s11030-023-10636-4","volume":"28","author":"V Srivastava","year":"2024","unstructured":"Srivastava V, Naik B, Godara P, Das D, Mattaparthi VSK, Prusty D (2024) Identification of FDA-approved drugs with triple targeting mode of action for the treatment of monkeypox: a high throughput virtual screening study. Mol Divers 28(3):1093\u20131107","journal-title":"Mol Divers"},{"key":"11421_CR443","doi-asserted-by":"publisher","DOI":"10.2174\/0109298673361923250101072831","author":"SK Mishra","year":"2025","unstructured":"Mishra SK, Chandra A, Mitra N, Krishna N, Singh N, Akash S et al (2025) Exploring the dynamics of Asparagus racemosus phytochemicals as dual target inhibitors of Monkeypox virus. Curr Med Chem. https:\/\/doi.org\/10.2174\/0109298673361923250101072831","journal-title":"Curr Med Chem"},{"issue":"10","key":"11421_CR444","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/S0165-6147(02)02091-6","volume":"23","author":"E De Clercq","year":"2002","unstructured":"De Clercq E (2002) Cidofovir in the therapy and short-term prophylaxis of poxvirus infections. Trends Pharmacol Sci 23(10):456\u2013458","journal-title":"Trends Pharmacol Sci"},{"key":"11421_CR445","doi-asserted-by":"publisher","DOI":"10.1002\/sstr.202400647","author":"V Chaudhary","year":"2025","unstructured":"Chaudhary V, Lucky L, Sable H, Bhalla N (2025) Interdisciplinary approach to Monkeypox prevention: integrating nanobiosensors, nanovaccines, artificial intelligence, visual arts, and social sciences. Small Struct. https:\/\/doi.org\/10.1002\/sstr.202400647","journal-title":"Small Struct"},{"key":"11421_CR446","doi-asserted-by":"publisher","first-page":"105692","DOI":"10.1016\/j.jcv.2024.105692","volume":"173","author":"B Chin","year":"2024","unstructured":"Chin B, Um J, Kim MK, Kim HS, Yim HS, Cho HJ et al (2024) Clinical presentation, viral shedding, and neutralizing antibody responses of mpox cases in South Korea: single center experience. J Clin Virol 173:105692","journal-title":"J Clin Virol"},{"issue":"2","key":"11421_CR447","doi-asserted-by":"publisher","first-page":"8443","DOI":"10.22207\/JPAM.17.2.52","volume":"17","author":"S Morris","year":"2023","unstructured":"Morris S, Joshi P, Soni P, Jakhmola V, Kalita K, Nainwal N et al (2023) A systematic review on human monkeypox virus disease and infection in pregnancy. J Pure Appl Microbiol 17(2):8443","journal-title":"J Pure Appl Microbiol"},{"key":"11421_CR448","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022-060179","author":"AM Beeson","year":"2023","unstructured":"Beeson AM, Haston J, McCormick DW, Reynolds M, Chatham-Stephens K, McCollum AM et al (2023) Mpox in children and adolescents: epidemiology, clinical features, diagnosis, and management. Pediatrics. https:\/\/doi.org\/10.1542\/peds.2022-060179","journal-title":"Pediatrics"},{"issue":"1","key":"11421_CR449","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pathogens14010001","volume":"14","author":"S Kumar","year":"2024","unstructured":"Kumar S, Guruparan D, Karuppanan K, Kumar KS (2024) Comprehensive insights into monkeypox (mpox): recent advances in epidemiology, diagnostic approaches and therapeutic strategies. Pathogens 14(1):1","journal-title":"Pathogens"},{"key":"11421_CR450","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11081345","author":"S Malik","year":"2023","unstructured":"Malik S, Ahmed A, Ahsan O, Muhammad K, Waheed Y (2023) Monkeypox virus: a comprehensive overview of viral pathology, immune response, and antiviral strategies. Vaccines. https:\/\/doi.org\/10.3390\/vaccines11081345","journal-title":"Vaccines"},{"key":"11421_CR451","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S395203","author":"Z Boswell","year":"2023","unstructured":"Boswell Z, Verga JU, Mackle J, Guerrero-Vazquez K, Thomas OP, Cray J et al (2023) In-silico approaches for the screening and discovery of broad-spectrum marine natural product antiviral agents against coronaviruses. Infect Drug Resist. https:\/\/doi.org\/10.2147\/IDR.S395203","journal-title":"Infect Drug Resist"},{"key":"11421_CR452","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40169-017-0181-2","volume":"7","author":"RR Ramsay","year":"2018","unstructured":"Ramsay RR, Popovic-Nikolic MR, Nikolic K, Uliassi E, Bolognesi ML (2018) A perspective on multi-target drug discovery and design for complex diseases. Clin Transl Med 7:1\u201314","journal-title":"Clin Transl Med"},{"issue":"3","key":"11421_CR453","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.imj.2023.05.004","volume":"2","author":"ZK Wei","year":"2023","unstructured":"Wei ZK, Zhao YC, Wang ZD, Sui LY, Zhao YH, Liu Q (2023) Animal models of mpox virus infection and disease. Infect Med 2(3):153\u2013166","journal-title":"Infect Med"},{"key":"11421_CR454","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.antiviral.2019.06.005","volume":"168","author":"M Merchlinsky","year":"2019","unstructured":"Merchlinsky M, Albright A, Olson V, Schiltz H, Merkeley T, Hughes C et al (2019) The development and approval of tecoviromat (TPOXX\u00ae), the first antiviral against smallpox. Antivir Res 168:168\u2013174","journal-title":"Antivir Res"},{"issue":"1","key":"11421_CR455","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1056\/NEJMoa1705688","volume":"379","author":"DW Grosenbach","year":"2018","unstructured":"Grosenbach DW, Honeychurch K, Rose EA, Chinsangaram J, Frimm A, Maiti B et al (2018) Oral tecovirimat for the treatment of smallpox. N Engl J Med 379(1):44\u201353","journal-title":"N Engl J Med"},{"issue":"7","key":"11421_CR456","doi-asserted-by":"publisher","first-page":"4514","DOI":"10.1039\/D0CS01084G","volume":"50","author":"Y Ma","year":"2021","unstructured":"Ma Y, Frutos-Beltr\u00e1n E, Kang D, Pannecouque C, De Clercq E, Men\u00e9ndez-Arias L et al (2021) Medicinal chemistry strategies for discovering antivirals effective against drug-resistant viruses. Chem Soc Rev 50(7):4514\u20134540","journal-title":"Chem Soc Rev"},{"issue":"17","key":"11421_CR457","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.2174\/1568026623666230201144522","volume":"23","author":"T Khan","year":"2023","unstructured":"Khan T, Raza S (2023) Exploration of computational aids for effective drug designing and management of viral diseases: a comprehensive review. Curr Top Med Chem 23(17):1640\u20131663","journal-title":"Curr Top Med Chem"},{"issue":"6","key":"11421_CR458","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1021\/acs.chemrev.0c00648","volume":"121","author":"AN Matthew","year":"2021","unstructured":"Matthew AN, Leidner F, Lockbaum GJ, Henes M, Zephyr J, Hou S et al (2021) Drug design strategies to avoid resistance in direct-acting antivirals and beyond. Chem Rev 121(6):3238\u20133270","journal-title":"Chem Rev"},{"key":"11421_CR459","doi-asserted-by":"publisher","DOI":"10.1016\/j.soh.2024.100085","author":"DB Olawade","year":"2024","unstructured":"Olawade DB, Wada OZ, Fidelis SC, Oluwole OS, Alisi CS, Orimabuyaku NF et al (2024) Strengthening Africa\u2019s response to Mpox (monkeypox): insights from historical outbreaks and the present global spread. Sci One Health. https:\/\/doi.org\/10.1016\/j.soh.2024.100085","journal-title":"Sci One Health"},{"issue":"7","key":"11421_CR460","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1016\/j.vaccine.2023.12.086","volume":"42","author":"FM Giorgi","year":"2024","unstructured":"Giorgi FM, Pozzobon D, Di Meglio A, Mercatelli D (2024) Genomic and transcriptomic analysis of the recent Mpox outbreak. Vaccine 42(7):1841\u20131849","journal-title":"Vaccine"},{"issue":"2","key":"11421_CR461","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1197\/jamia.M1356","volume":"11","author":"KD Mandl","year":"2004","unstructured":"Mandl KD, Overhage JM, Wagner MM, Lober WB, Sebastiani P, Mostashari F et al (2004) Implementing syndromic surveillance: a practical guide informed by the early experience. J Am Med Inform Assoc 11(2):141\u2013150","journal-title":"J Am Med Inform Assoc"},{"key":"11421_CR462","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpbup.2024.100146","author":"M Khalifa","year":"2024","unstructured":"Khalifa M, Albadawy M (2024) AI in diagnostic imaging: revolutionising accuracy and efficiency. Comput Methods Programs Biomed Update. https:\/\/doi.org\/10.1016\/j.cmpbup.2024.100146","journal-title":"Comput Methods Programs Biomed Update"},{"key":"11421_CR463","doi-asserted-by":"publisher","first-page":"101487","DOI":"10.1016\/j.nmni.2024.101487","volume":"62","author":"P Singh","year":"2024","unstructured":"Singh P, Sridhar S, Shareef J, Talath S, Mohapatra P, Khatib M et al (2024) The resurgence of monkeypox: epidemiology, clinical features, and public health implications in the post-smallpox eradication era. New Microbes New Infect 62:101487","journal-title":"New Microbes New Infect"},{"issue":"4","key":"11421_CR464","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.pop.2015.08.006","volume":"42","author":"P Ramdass","year":"2015","unstructured":"Ramdass P, Mullick S, Farber HF (2015) Viral skin diseases. Prim Care 42(4):517\u2013567","journal-title":"Prim Care"},{"issue":"5","key":"11421_CR465","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3390\/v16050784","volume":"16","author":"BM Liu","year":"2024","unstructured":"Liu BM, Rakhmanina NY, Yang Z, Bukrinsky MI (2024) Mpox (Monkeypox) virus and its co-infection with HIV, sexually transmitted infections, or bacterial superinfections: double whammy or a new prime culprit? Viruses 16(5):784","journal-title":"Viruses"},{"issue":"1","key":"11421_CR466","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12985-024-02392-0","volume":"21","author":"A Azzam","year":"2024","unstructured":"Azzam A, Khaled H, Salem H, Ahmed A, Heniedy AM, Hassan HS et al (2024) The impact of immunosuppression on the mortality and hospitalization of Monkeypox: a systematic review and meta-analysis of the 2022 outbreak. Virol J 21(1):130","journal-title":"Virol J"},{"issue":"8","key":"11421_CR467","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/hiv.13622","volume":"25","author":"AM Taha","year":"2024","unstructured":"Taha AM, Elrosasy A, Mahmoud AM, Saed SAA, Moawad WAE, Hamouda E et al (2024) The effect of HIV and mpox co-infection on clinical outcomes: systematic review and meta-analysis. HIV Med 25(8):897\u2013909","journal-title":"HIV Med"},{"key":"11421_CR468","doi-asserted-by":"crossref","unstructured":"Hurst JR, Tan DHS, Li A, Khera SS, Persaud R, Chan A, et al (2025) Monkeypox virus transcriptional profiles and host responses in skin lesion swabs among individuals with HIV. J Infect Dis","DOI":"10.1093\/infdis\/jiaf316"},{"issue":"1","key":"11421_CR469","doi-asserted-by":"publisher","first-page":"2459136","DOI":"10.1080\/22221751.2025.2459136","volume":"14","author":"Y Liu","year":"2025","unstructured":"Liu Y, Liu X, Wang J, Xie Y, Guo J, Liu Z et al (2025) Single-cell sequencing of peripheral blood mononuclear cells reveals immune landscape of monkeypox patients with HIV. Emerg Microbes Infect 14(1):2459136","journal-title":"Emerg Microbes Infect"},{"issue":"7","key":"11421_CR470","doi-asserted-by":"publisher","first-page":"e70498","DOI":"10.1002\/jmv.70498","volume":"97","author":"O Calle-Jim\u00e9nez","year":"2025","unstructured":"Calle-Jim\u00e9nez O, Casado-Fern\u00e1ndez G, Armenteros-Yeguas I, Lemus-Aguilar L, Baza B, P\u00e9rez-Garc\u00eda JA et al (2025) Low specific T-cell immunity against mpox elicited in people with HIV-1 and PrEP users after subcutaneous vaccination compared to natural infection. J Med Virol 97(7):e70498","journal-title":"J Med Virol"},{"key":"11421_CR471","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ijid.2022.10.031","volume":"125","author":"C Viguier","year":"2022","unstructured":"Viguier C, de Kermel T, Boumaza X, Benmedjahed NS, Izopet J, Pasquier C et al (2022) A severe monkeypox infection in a patient with an advanced HIV infection treated with tecovirimat: clinical and virological outcome. Int J Infect Dis 125:135\u2013137","journal-title":"Int J Infect Dis"},{"key":"11421_CR472","unstructured":"Oom AL, Kottkamp AC, Wilson KK, Yonatan M, Rettig S, Youn HA, et al (2024) The durability and avidity of MPXV-specific antibodies induced by the two-dose MVA-BN Mpox vaccine. medRxiv. 2024.01.28.24301893."},{"issue":"49","key":"11421_CR473","doi-asserted-by":"publisher","first-page":"45023","DOI":"10.1021\/acsomega.2c05376","volume":"7","author":"J Zhang","year":"2022","unstructured":"Zhang J, He M, Xie Q, Su A, Yang K, Liu L, Wang Y (2022) Predicting in vitro and in vivo anti-SARS-CoV-2 activities of antivirals by intracellular bioavailability and biochemical activity. ACS Omega 7(49):45023\u201345035. https:\/\/doi.org\/10.1021\/acsomega.2c05376","journal-title":"ACS Omega"},{"key":"11421_CR474","doi-asserted-by":"publisher","first-page":"903","DOI":"10.2147\/IDR.S505311","volume":"18","author":"Y Yang","year":"2025","unstructured":"Yang Y, Li C, Fan X, Long W, Hu Y, Wang Y, Qu J (2025) Effectiveness of omadacycline in a patient with chlamydia psittaci and kpc-producing gram-negative bacteria infection. Infect Drug Resistance 18:903\u2013908","journal-title":"Infect Drug Resistance"},{"key":"11421_CR475","doi-asserted-by":"publisher","first-page":"126635","DOI":"10.1016\/j.vaccine.2024.126635","volume":"45","author":"J Yang","year":"2025","unstructured":"Yang J, Yao YL, Lv XY, Geng LH, Wang Y, Adu-Gyamfi EA, Wang XJ, Qian Y, Chen MX, Zhong ZH, Li RY, Wan Q, Ding YB (2025) The safety and efficacy of inactivated COVID-19 vaccination in couples undergoing assisted reproductive technology: a prospective cohort study. Vaccine 45:126635. https:\/\/doi.org\/10.1016\/j.vaccine.2024.126635","journal-title":"Vaccine"},{"issue":"2","key":"11421_CR476","doi-asserted-by":"publisher","first-page":"2263229","DOI":"10.1080\/21645515.2023.2263229","volume":"19","author":"HQ Zhang","year":"2023","unstructured":"Zhang HQ, Cao BZ, Cao QT, Hun M, Cao L, Zhao MY (2023) An analysis of reported cases of hemophagocytic lymphohistiocytosis (HLH) after COVID-19 vaccination. Hum Vaccin Immunother 19(2):2263229. https:\/\/doi.org\/10.1080\/21645515.2023.2263229","journal-title":"Hum Vaccin Immunother"},{"key":"11421_CR477","doi-asserted-by":"publisher","first-page":"112758","DOI":"10.1016\/j.microc.2025.112758","volume":"209","author":"H Zeng","year":"2025","unstructured":"Zeng H, Zhang Y, Zhang M, Liu H, Liu J, Zhu L, Guo W (2025) A signal enhanced lateral flow immunoassay based on core\u2013shell quantum dots labeled antibody and antigen for sensitive detection of CP4-EPSPS protein. Microchem J 209:112758. https:\/\/doi.org\/10.1016\/j.microc.2025.112758","journal-title":"Microchem J"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11421-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-025-11421-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11421-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T11:02:24Z","timestamp":1783162944000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-025-11421-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":478,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["11421"],"URL":"https:\/\/doi.org\/10.1007\/s11030-025-11421-1","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}